NUGGET EXPLORATION INC
DEF 14C, 2000-01-03
GOLD AND SILVER ORES
Previous: USAA TAX EXEMPT FUND INC, 497, 2000-01-03
Next: IRVINE SENSORS CORP/DE/, 10-K, 2000-01-03



                            SCHEDULE 14C INFORMATION
                 Information Statement Pursuant to Section 14(c)

                       of the Securities Exchange Act 1934

Check the appropriate box:

      [ ] Preliminary Information Statement

      [ ] Confidential,  for Use  of the  Commission  Only (as permitted by Rule
          14a-6(e)(2))

      [X] Definitive Information Statement

                            NUGGET EXPLORATION, INC.
                            ------------------------
                (Name of Registrant as Specified in Its Charter)

Payment of Filing Fee (Check the appropriate box):

[X]  No fee required.

[ ] Fee computed on table below per Exchange Act Rules 14c-5(g) and 0-11.

         1) Title of each class of securities to which transaction applies.

         2) Aggregate number of securities to which transaction applies:

         3) Per unit price or other  underlying  value of  transaction  computed
         pursuant to Exchange Act Rule 0-11.  (Set forth the amount on which the
         filing fee is calculated and state how it was determined.)

         4) Proposed maximum aggregate value of transaction:

         -----------------------------------------------------------

[  ]     Fee paid previously by written preliminary materials.

[        ] Check box if any part of the fee is offset as  provided  by  Exchange
         Act Rule  0-11(a)(2)  and identify the filing for which the  offsetting
         fee was paid  previously.  Identify the previous filing by registration
         statement number, or the Form of Schedule and the date of its filing.

         1)  AMOUNT PREVIOUSLY PAID:
         2)  FORM, SCHEDULE OR REGISTRATION STATEMENT NO.:
         3)  FILING PARTY:
         4)  DATE FILED:


<PAGE>



                              INFORMATION STATEMENT
                                       OF
                            NUGGET EXPLORATION, INC.
                              2051 SPRINGDALE ROAD
                              CHERRY HILL, NJ 08003
                             TELEPHONE: 800-204-1902

                    WE ARE NOT ASKING YOU FOR A PROXY AND YOU
                      ARE REQUESTED NOT TO SEND US A PROXY.

- --------------------------------------------------------------------------------


               NOTICE OF SHAREHOLDER CONSENT TO CHANGE THE NAME OF
                            NUGGET EXPLORATION, INC.
                                       TO
                                GOHEALTH.MD, INC.

         We are providing  this  Information  Statement to all  shareholders  as
notification that the holders of a majority of our outstanding common stock, par
value $0.01 ("Common Stock"), voted to change our name to "GoHealth.MD, Inc."

         On November 10,  1999,  holders of a majority of the Common Stock voted
to amend our Articles of Incorporation  to change our name to GoHealth.MD,  Inc.
Of the 3,799,117 shares issued and outstanding on that date, shareholders owning
3,102,000 shares, or 82% of the outstanding  Common Stock, voted to approve this
name  change via written  consent  taken  without a meeting  pursuant to Section
78.320 of the Nevada Revised Statutes.

         On December 31, 1999, we expect to send this  Information  Statement to
all  shareholders  of record as of  December 1, 1999.  The name change  shall be
effective twenty (20) calendar days after this  Information  Statement is mailed
to our shareholders. The effective date for this corporate action is expected to
be January 20, 2000.

         The  shareholders  who  consented  to the name change  were  previously
shareholders of GoHealth.MD,  Inc., a Delaware corporation  ("GoHealth").  These
entities  received  shares of Common  Stock  when our wholly  owned  subsidiary,
Nugget Holding Company, a Delaware corporation  ("Newco"),  merged with and into
GoHealth,   pursuant  to  a  Stock   Exchange   Agreement  and  Plan  of  Merger
("Agreement"), dated September 30, 1999. GoHealth survived the merger and became
our  wholly  owned  subsidiary.  For  more  information  on the  Agreement,  see
"Description of Business."

         We have not  conducted  any  operations  for  several  years.  When we,
through Newco, merged with GoHealth, our operational focus shifted to GoHealth's
Internet-related marketing services. Our board of directors recommended the name
change to GoHealth.MD, Inc. to reflect our new focus on GoHealth's operations.

                                        1


<PAGE>



                          SECURITY OWNERSHIP OF CERTAIN
                        BENEFICIAL OWNERS AND MANAGEMENT

         The following table sets forth certain information concerning ownership
of our Common Stock as of December 1, 1999.  The table  discloses each entity we
know to  beneficially  own more than five percent (5%) of our common stock.  The
table also shows the stock holdings our directors, as well as the shares held by
our directors  and executive  officers as a group.  The notes  accompanying  the
information in the table below are necessary for a complete understanding of the
figures provided.

<TABLE>
<CAPTION>
                                      Name and Address                     Amount and Nature of           Percent of
    Title of Class                  of Beneficial Owner                    Beneficial Ownership             Class
<S>                           <C>                                           <C>                      <C>

                                MCOM Management Corporation
     Common Stock               350 Fifth Avenue, Suite 5807                    800,000(1)                 17.4%(2)
                                     New York, NY 10118

                                       Sandra Vernon
     Common Stock                   2051 Springdale Road                        2,000,000                   48.8%
                                   Cherry Hill, NJ 08003

                                      William D. Hanna
     Common Stock                   2051 Springdale Road                        615,000(3)                 14.6%(4)
                                   Cherry Hill, NJ 08003

                                     Dr. Leonard Vernon
     Common Stock                   2051 Springdale Road                       2,000,000(5)                 48.8%
                                   Cherry Hill, NJ 08003

                                      Kevin O'Donnell
     Common Stock                   2051 Springdale Road                        615,000(6)                 14.6%(7)
                                   Cherry Hill, NJ 08003

     Common Stock                  Executive Officers and                       3,230,000                 77.8% (8)
                                    Directors as a Group
</TABLE>


         (1) Includes  450,000  shares of our common stock which may be acquired
upon the exercise of outstanding warrants held by MCOM.

         (2) Such  percentage  presumes  the  issuance of those shares of common
stock referenced in note 1 above.

         (3) Includes  115,000  shares of our common stock which may be acquired
upon the exercise of outstanding stock options held by Mr. Hanna.

         (4) Such  percentage  presumes  the  issuance of those shares of common
stock referenced in note 3 above.

                                        2


<PAGE>



         (5) Includes  2,000,000 shares owned by Sandra Vernon,  the wife of Dr.
Leonard Vernon. Dr. Vernon disclaims any beneficial ownership of such shares.

         (6) Includes  115,000  shares of our common stock which may be acquired
upon the exercise of outstanding stock options held by Mr. O'Donnell.

         (7) Such  percentage  presumes  the  issuance of those shares of common
stock referenced in note 6 above.

         (8) Such  percentage  presumes  the  issuance of those shares of common
stock referenced in notes 4 and 6 above.

                                CHANGE IN CONTROL

         We experienced a change of control on November 10, 1999, when we issued
3,102,000 shares of our common stock to the shareholders of GoHealth.MD, Inc., a
Delaware  corporation  ("GoHealth"),  pursuant to a Stock Exchange Agreement and
Plan of Merger ("Merger  Agreement"),  dated September 30, 1999. Pursuant to the
terms of the  Merger  Agreement,  each of the  3,102,000  outstanding  shares of
GoHealth common stock (the "GoHealth  Stock"),  was converted into and exchanged
for one share of our common stock.

         The Merger Agreement  additionally  provided that we assume  GoHealth's
rights and obligations  under all of its outstanding stock options and warrants.
All  holders of such  options  and  warrants  agreed  upon the  exercise of such
securities to accept  shares of our common stock.  In the event all such options
and warrants are exercised,  we will issue an additional  567,000 shares,  which
will result in total issuances of a total of 3,669,000 shares of common stock to
GoHealth stockholders.  If all GoHealth options and warrants are exercised,  the
GoHealth  stockholders will have received 77.9% of the total number of shares of
common stock  outstanding.  All shares  issued  pursuant to the  Agreement  were
issued  pursuant to exemptions  from  registration  under the  Securities Act of
1933, as amended (the "Act"), including Rule 506 under the Act.

         Sandra  Vernon,  William Hanna,  Kevin  O'Donnell now own in aggregate,
presuming  the exercise of all warrants  held by Hanna and  O'Donnell  described
above in Security Ownership of Certain  Beneficial Owners and Management,  77.8%
of our  common  stock,  respectively,  which  provide  them with  control of the
Company.  Sandra Vernon is the wife of Dr. Leonard Vernon,  one of our directors
and our  president.  Control  was  assumed  from  Mr.  Kurtz,  who at that  time
beneficially  owned 348,709 shares of Common Stock,  which represented 50.02% of
the outstanding Common Stock prior to the GoHealth  acquisition.  Kurtz now owns
approximately  57,709  shares of  Common  Stock,  representing  1.5% of that now
outstanding.   We  understand  that   subsequent  to  the  Merger,   Kurtz  sold
approximately  291,000 shares of Common Stock to various  investors in a private
transaction.

         In  connection  with these  stock  issuances,  Dr.  Leonard  Vernon and
William Hanna were appointed as additional directors. Tyson Schiff then resigned
from his  positions as  president  and  director,  and Brian Ortega and Marianne
Brady resigned as directors.  The directors then appointed Dr. Leonard Vernon as

                                        3


<PAGE>



president and William Hanna as its secretary and treasurer.  Neither Mr. Schiff,
Mr.  Ortega  nor Ms.  Brady had any  disagreements  with us at the time of their
respective resignations. This change of control in our management coincided with
a change in control of the ownership of our capital stock.

         We know of no other  arrangements  which may  result in a change in our
control.

                             DESCRIPTION OF BUSINESS

         The Internet related operations of GoHealth.MD,  Inc.  ("GoHealth") now
comprise virtually all of our activities.  These activities are conducted in two
arenas.  GoHealth  sells  Internet  domain  names with the ".MD"  extension,  as
compared to the more standard domain  extensions  .com,  .org, .net or .edu, and
operates an informational  Internet site,  Healthmall.com.  As used hereinafter,
the terms such as  "Company,"  "we," "us" or "our"  refer to Nugget  Exploration
Inc.,  a  Nevada  corporation,  and  our  subsidiary  (including  GoHealth)  and
predecessors, unless the context indicates otherwise.

HEALTHMALL.COM

         We  operate  an   informational   site  on  the  Internet   located  aT
www.Healthmall.com. This site is devoted to providing information related to the
use of herbs,  vitamins, as well as an information source for alternative health
care providers  such as  chiropractors  and  naturopathic  physicians.  The site
therefore  serves as an information  portal for  alternative  health care and is
very heavily content based. Among the vast quantities of information that can be
garnered  on  the  site  is  herb  and  prescription  drug  interactions.   This
information is supplied on the site through a licensing  contract with Facts and
Comparisons  Corporation,   one  of  the  leading  sources  of  information  for
pharmacists in the United States.

         The site  includes a  continuously  updated  news wire feed  limited to
health care from PR Newswire, a searchable database through the National Library
of Medicine for published peer review medical journal articles known as "Medline
search," and  information  on almost 200 herbs,  including  their  pharmacology,
toxicology, and their clinical indications.

         We also feature one of the largest  databases  in the United  States of
health food stores.  This database  contains over 5000 health food stores in the
United States and includes their name,  address,  and phone number. The database
is constantly being updated and expanded.

         Databases  of  alternative  health  care  providers,  such as  licensed
chiropractors, massage therapists and naturopathic physicians are also contained
on the site.  The site  contains a database of over 3,000  chiropractors  in the
United  States.  It is  our  goal  to  establish  an  online  presence  for  the
chiropractor  by  developing a website as well as an e-mail  account.  This will
initially  be done  free-of-charge  for  six  months.  Again,  at the end of six
months,  the  chiropractor  will have the option of staying online for an annual
fee of $150 or  terminate  the  service.  In the event  these  options  prove of
interest to  chiropractors,  we plan to utilize  similar option for other health
care practitioners.

                                        4


<PAGE>



         The site also offers the following options and services:

                  SYMPTOMS  AND  REMEDIES:  An  extensive  database of symptoms,
                  diseases,  and  medical  conditions  that  offers  viewers the
                  opportunity  to  read a  short  description  of  the  symptom,
                  disease,  or condition,  as well as view the associated herbal
                  remedies  and/or  prescription  medications  that are commonly
                  used to treat that condition.

                  SHOPPING: A health food/health product "mall" with specialized
                  stores, shops, and services.  The shopping section offers each
                  store a home page,  unlimited  product  categories,  unlimited
                  product  descriptions  and/or  photos,  as  well  as a  secure
                  e-commerce connection to complete ordering transactions

                  HEALTH CHAT: A chat room in which people can ask  questions or
                  chat about health-related  topics,  concerns, and information.
                  We also offer chat sessions with experts in various fields who
                  offer  advice  and  lectures,  as well as  interact  with  the
                  Internet community in scheduled question and answer sessions.

         We are currently  gathering data on the purchasing  habits of consumers
regarding their vitamin and  nutritional  supplement  purchases.  We hope to use
this information in the future as an information source to develop an e-commerce
relationship with vitamin manufacturers and retailers.

         Healthmall.com is targeted to well-educated,  technology adopting women
aged 25-54 who are proactive in seeking  information to actively  maintain their
health and  well-being  and reactive in  addressing  health and medical  issues.
Healthmall.com's  target  market is  predominantly  female,  as they are the key
healthcare decision-makers within the household. According to International Data
Corporation,  women are expected to represent approximately 51% of on-line users
in 1999, up from 46% in 1998.  Healthmall.com  believes that women  represent an
attractive  demographic group for advertisers  since they have  disproportionate
control over consumer  spending in the United States.  Industry experts estimate
that women make 75% of the household's healthcare decisions,  control 66% of the
health dollars and spend 80% of a household's discretionary income.

 .MD DOMAIN NAMES

         We have a strategic  partnership  with a Florida  company,  Domain Name
Trust ("DNT"),  which has a licensing  agreement with the country of Moldova,  a
small  Eastern  European  country  which was assigned a monopoly  over the ".MD"
top-level domain extension by the Internet Assigned Numbers Authority,  a United
States  government  agency,  in conjunction  with a United Nations  organization
known as ISO, or International Organization for Standardization.

         A domain name is the  equivalent of an address on Internet.  Therefore,
every site on the Internet has a domain name identifying it. There are two types
of top-level domains, generic and country code. Generic domains were created for
use by the Internet  public,  while country code domains were created to be used
by each individual country as they deemed necessary.

                                        5


<PAGE>



         In the Domain Name System ("DNS")  naming of computers,  a hierarchy of
names  exists.  There  are a set of what are  called  "top-level  domain  names"
("TLDs").  These are the generic TLDs (EDU,  COM,  NET, ORG, GOV, MIL, and INT),
and the two letter country  codes.  Under each TLD may be created a hierarchy of
names.  Generally,  under the generic TLDs the structure is very flat.  That is,
many  organizations  are  registered  directly  under the TLD,  and any  further
structure is up to the individual organizations.

         The .MD  domain  names are sold  directly  from our  Internet  website,
located at WWW.GOHEALTH.MD. Anyone can access this site and acquire an available
domain with the .MD extension.  The site is 'branded,' or electronically linked,
to DNT's site, which maintains record of new .MD domains.  Therefore, every time
a person at our site registers a .MD domain, DNT's site recognizes the origin of
the sale as our,  ensuring  that we receive  credit for each and every sale of a
 .MD domain name generated through our site.

         We have acquired the marketing rights to more than 40 domain names that
end in the  domain  extension  .MD.  Each  one of  these  domain  names  have an
unlimited  marketing  potential since they can be specifically  identified by an
individual URL. An example of this would be BACKDOC.MD/SMITH.  Thus, a virtually
unlimited  number of specialists in any given specialty will have the ability to
use the .MD domain  name of their  particular  choice.  Other .MD  domain  names
acquired  by  GoHealth  include  www.Ask.md,  www.Call911.md,  www.nutrition.md,
www.Family.md.  We believe  the ".MD"  extension  is and will  continue  to be a
highly desired domain  extension in the medical industry which is more appealing
than comparable extensions of ".COM", ".NET", ".ORG" or ".EDU".

OFFICE FACILITIES

         Our offices are  located at 2051  Springdale  Road,  Cherry  Hill,  New
Jersey,  which also houses the offices of Able  Imaging,  Inc.,  a wholly  owned
entity of  William D.  Hanna,  one of our  directors.  We do not pay rent to Mr.
Hanna for such facilities.

                         MANAGEMENT'S PLAN OF OPERATION

         This Information  Statement contains  forward-looking  statements.  For
this  purpose,  any  statements  contained  herein  that are not  statements  of
historical fact may be deemed to be forward-looking statements. Without limiting
the foregoing,  the words  "believes,"  "anticipates,"  "plans,"  "expects," and
similar expressions are intended to identify forward-looking  statements.  There
are a number of important  factors that could cause our actual results to differ
materially from those indicated by such forward-looking statements.

         Our  operations  are  conducted  through our wholly  owned  subsidiary,
GoHealth,  which  is  a  development  stage  company.  We  operate  an  Internet
informational  site  relating to health and medicine and sells  Internet  domain
names with the ".MD" extension.

         Capturing a large physician  network (medical  doctors,  chiropractors,
dentists,  podiatrists,  osteopaths) to view online  advertising in exchange for
the establishment of  websites and hosting services is one of our primary goals.

                                        6


<PAGE>



Such  a  network  would  facilitate  a  synergy  between   GoHealth's   Internet
informational site and .MD domain names. We hope to entice physicians to utilize
its  Internet  website  design  services  with one of its  Internet  .MD  domain
extensions.  We hope  to have  advertisers,  such as  pharmaceutical  companies,
underwrite physician's cost of a .MD domain and website.

         The medical  industry does not utilize  advertising  on the Internet as
much  as  many  other  industries.  However,  we  hope  to  alter  this  lack of
advertising with its .MD domain extensions, which in our opinion, allow for easy
recognition of a physician's  website.  Physicians  interested in the .MD domain
extensions  will be offered  discount  packages to encourage  them to assist our
informational  site.  The presence of  physicians  participating  on our site is
expected to establish a significant potential for advertising revenue.

HEALTHMALL.COM

         By  developing   Healthmall.com  into  the  leading  Internet  resource
dedicated to the use of herbs,  vitamins,  as well as an information  source for
alternative  health  care  providers  such  as  chiropractors  and  naturopathic
physicians,  we  believe  we will be able to  generate  substantial  advertising
revenues.  We have  entered  into,  and  intend to  continue  to enter  into new
distribution  and business  relationships  with entities  that have  significant
reach on the  Internet  and are in  similar  fields,  such as  pharmacy  chains,
Internet access  providers and portals,  as well as other  traditional  media to
build the  Healthmall.com  brand and drive traffic to the site.  Since launching
the  site,  we have  developed  advertising  relationships  with  the  following
companies:  Onhealth.com,  Dr.  Koop.com,  Pharmor.com,  Natraflex,  The  Simple
Truth.com, Vivacity.com,  Nature's Source's, Permalean, Nutriceutical Technology
Corporation, Northeast Health Institute and Nourishing Foods, Inc. Many of these
advertising contracts have been brought to the site via an agreement with Burst!
Media. Current distribution relationships include:

         THE  GOTO.COM  SEARCH  ENGINE.  This  search  engine  is  basically  an
         auction-type search engine that allows individual websites to bid for a
         position  in the search  engine.  Healthmall.com  has almost 300 search
         terms which appear on the first page of the search engine.

         THE YAHOO SEARCH ENGINE.  Healthmall.com also has  rankings that permit
         direct traffic to our site from the YAHOO search engine.

         THE ALTA VISTA SEARCH ENGINE. Healthmall.com not only also has rankings
         that  permit  direct  traffic  to our site from the ALTA  VISTA  search
         engine,  but the Company has search engine positioning with REAL NAMES.
         This  permits us to purchase  various  names that will appear  first on
         ALTA VISTA search engines.

         Familiarity of the domain, or address,  of a website  containing health
and medical  information  is, in our opinion,  a  competitive  advantage as many
consumers may desire to avoid searching for an unknown  website.  We believe our
website has a familiar, easy to remember domain.  Internet-related marketing and
advertising  revenues are tied directly to the amount of 'hits' a site receives,
or  times the site is  visited.  In the event we are able to generate a  greater

                                        7


<PAGE>



viewing market, we expect to generate higher advertising and marketing revenues.

         Healthmall.com is attempting to reach independent health food stores at
this time to offer them an online  presence  and to  increase  our  database  of
retail natural food stores. While GNC and Great Earth possess the largest market
segments,  and Mother  Nature.com is an Internet-  based  superstore that offers
nutritional products,  the remainder of the market is comprised of approximately
8,000  small,  independent  retailers  with no  uniformity.  There is no ongoing
consolidation  of  independent  health food stores in the United  States and the
independents are facing increasing  competition from the chains, such as GNC and
Great Earth, as well as online chains, such as Vitamins.com and Vitaminshop.com.

         If even a small  portion  of these  approximately  8,000  these  small,
independent health food retailers can be combined and linked at an Internet site
such as  Healthmall.com,  we believe they will have the  opportunity  to compete
with the  superstores  on a national  level.  We are  attempting to achieve this
through a free offer that allows the independent health food store to get a free
website and free online  shopping cart for six months.  Such technical  services
are being  provided to us by World Wide Web  Communications  of Cherry Hill, New
Jersey.  Following the six-month trial period,  if the  independent  health food
store wishes to remain online,  there is a cost of $20 per month.  This presence
would allow the independent retailer the opportunity to advertise their business
on a national  level,  as well as to their  existing  customers and  prospective
customers in their own community.

         One manner by which we hope to differentiate  the  Healthmall.com  site
from other sources of health and Wellness  information is by continuing to focus
on the  alternative  medicine.  While other sites only devote  portions of their
content to this type of alternative  medicine,  we intend to predominantly focus
on the use of herbs,  vitamins,  and  alternative  health care providers such as
chiropractors and naturopathic physicians.

         In an  attempt  to  further  differentiate  Healthmall.com  from  other
Internet  health  sites,  we have  designed  it to  allow  consumers  to  obtain
information  on specific  diseases or  conditions  and allergy  information  and
participate in relevant  discussion groups,  among other things.  Healthmall.com
provides updated health-related news articles from around the world are received
every 20 minutes via PR Newswire.  This feature always includes a cover story on
the  Healthmall.com  home page, as well as hundreds of additional  news articles
accessible from Healthmall.com's home page, located at www.Healthmall.com.

         The  licensing  arrangement  with  Facts  and  Comparison  Corporation,
referred  to  in  "Description  of  Business"  above,  which  allows  medication
information  to  appear  directly  on  Healthmall.com,   identifies  a  goal  of
Healthmall.com.   Very  few  of  the  several  informational  options  found  on
Healthmall.com  are  cobranded,  or  require  transfer  to a site  removed  from
Healthmall.com.   Therefore,   with  a  few  minor  exceptions,   a  visitor  to
Healthmall.com  remains on  Healthmall.com's  pages.  This  retained  viewing is
perceived  by the  Company  to be a  competitive  advantage  in its  attempt  to
generate advertising revenues.



                                        8


<PAGE>


".MD" DOMAIN NAMES

         We  currently  own and  operate  a website  for the sale of .MD  domain
names.  We  believe  that our use of the  domain  name .MD  carries  significant
marketability  and that medical  specialists that perform  elective  procedures,
such as plastic or  cosmetic  surgeon  have been  increasing  their  spending on
advertising  revenues as evidenced by viewing the yellow page book in the United
States or major regional magazines.

         In  conjunction  with  our  offering  of .MD  domain  names,  we  offer
physician  websites and the hosting of these websites on our own server which is
included  in the .MD domain name  purchase  price.  The  website is  basically a
templated  website that has been  designed by World Wide Web  Communications  of
Cherry Hill, New Jersey.  In addition,  we sell customized  websites,  which are
also  prepared  by World Wide Web  Communications  of Cherry  Hill,  New Jersey.
Hosting of websites  sold in  conjunction  with .MD domain names are provided by
Domain Name Trust, as more fully discussed in "Business."

         The limited  marketing of the .MD domain names and our related Internet
services which has occurred has consisted of  advertising  in medical  journals,
direct mail to  physicians,  as well as a point of  presence at various  medical
conventions.

TECHNOLOGY AND SYSTEMS

         Both  of  our  website  www.Healthmall.com,  www.GoHealth.md  are  made
available with the latest Internet  hardware and software  technologies.  Exodus
IT-class  co-location  facilities  provide a secure,  high availability and high
bandwidth space for our servers. This includes redundant OC-3 and OC-12 backbone
connections  to  the  Internet,   uninterruptible  power  supplies  with  diesel
generator  backup,  all  housed in a  copper-lined,  earthquake-proof  building.
Direct  connections  via "T-1" and DSL lines  allow the main  office to  connect
seamlessly  and reliably to the servers and the  Internet.  A farm of Intergraph
IS-8000  and IS80  mission-critical  servers are housed  behind a  redundant  F5
Big/IP  switcher for complete  software and hardware  fault  tolerance  and load
leveling. These servers run Microsoft Windows NT Enterprise Server with Internet
Information  Server 4.0,  Active  Server Pages with a  proprietary  page caching
system and publishing tools for Web page hosting and production management.  The
resulting   performance  in  preliminary   tests  shows   dominance  over  other
competitive  sites. All  advertisement  hosting and reporting is handled through
NetGravity Ad Server, a powerful ad management and forecasting toolset.

         The  website's  Personal  Health  Tracker and Search  features  utilize
Microsoft  SiteServer tools and  technologies.  This provides the customized web
crawling, user profile management,  nightly process runs and e-mail support that
the Personal Health Tracker requires.

         Microsoft  SQL  Server  databases  are  heavily  used for all  content,
process   management  and  tracking  needs.   Offsite  backups  occur  regularly
throughout the day to protect against a total system failure.

         We believe the site is a very stable,  scalable,  and high  performance
solution for Healthmall.com's current and future needs.

                                        9


<PAGE>



COMPETITION

         We currently face competition in the domain name registration  business
from other  registries for ccTLDs,  resellers,  registrars and registries of the
top-level  domains .com, .net and .org,  including  Network  Solutions,  Inc. In
developing and distributing  future products and services for the Internet-based
services  markets,  we face  intense  competition  and  expect to have  multiple
competitors  for each of the  products or  services,  if any,  which we develop,
market  or sell.  For  example,  with  respect  to our  healthcare  and  medical
information portal we plan to develop,  we will be competing with many companies
that  have  greater  experience  and  brand  recognition  than we do,  including
Healtheon Companies,  Inc., DrKoop,  Careinsite and Webmd. Increased competition
could result in pricing  pressures,  reduced  sales,  margins,  profits,  and/or
market  share or the  failure of our  products  to achieve  or  maintain  market
acceptance.  Furthermore,  the  industry  in  which  we  intend  to  compete  is
characterized by rapid changes and frequent product and service introductions.

         Many  of our  current  and  potential  competitors  have  significantly
greater financial,  marketing,  customer support,  technical and other resources
than we do.  Some of our  competitors  and  potential  competitors  have  longer
operating histories, greater name recognition,  access to larger customer bases,
more established  distribution  channels or substantially greater resources than
we have.  As a result,  they may be able to respond  more quickly than we can to
new or changing opportunities, technologies, standards or customer requirements.

ONLINE COMPETITORS

         There is significant  interest in  health-related  content among online
consumers.  Demographic  factors and the growth of online audiences suggest that
the  popularity  of this content will  continue to  increase.  Similarly,  major
health  advertisers  are showing  increased  levels of interest in the Internet.
Some key operators of health-related sites on the Internet today include:

o        DIVISIONS OR AFFILIATES OF PRINT  PUBLISHERS;  including  Healthy Ideas
         (Rodale  Press),  PHYS (Conde Nast),  Thrive  (owned by Oxygen  Media),
         MediConsult,  Dr. Koop and HealthScout (a service of RX Remedy, Inc., a
         market research firm.)

o        VENTURES OF ONLINE SERVICE FIRMS;  including  Better Health  (iVillage)
         and Thrive (owned by Oxygen Media), Medscape and WebMD.

o        PUBLIC SECTOR AND INSTITUTIONAL SITES; including the National institute
         of Health, Mayo Clinic,  InteliHealth and university sites. While these
         sites  compete for viewer  time and  attention,  they do not  typically
         compete for advertising or transactional revenues.

o        PORTALS/SEARCH  ENGINES;  principally  the  proprietary  health-related
         content  presented to subscribers to America Online,  MSN.com,  Yahoo!,
         Excite, etc.

o        INTERNET  SITES  OTHER THAN  HEALTH-RELATED  SITES;  including  general

                                       10


<PAGE>



         interest sites, such as news sites and search engines, which often host
         some   health-related   content  in  the  context  of  other  editorial
         materials.

                              FINANCIAL STATEMENTS

         Our financial  statements for the fiscal years ending May 31, 1999, and
1998 have been audited by Jones, Jensen & Company, independent auditors, and are
set forth on page 20 herein.  Audited  financial  statements of GoHealth through
September  30, 1999,  and pro forma  financial  statements  have been audited by
Samuel Klein & Co., independent auditors, and are set forth on page 33 herein.

                CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON
                       ACCOUNTING AND FINANCIAL DISCLOSURE

         As a result of our merger,  we have retained the services of our merger
partner's  independent  certified public  accountant,  Samuel Klein & Co., as of
December 1, 1999, for all of our needs.  Jones,  Jensen & Company,  our previous
accountant  ("Jones,  Jensen"),  was  dismissed  by our  board of  directors  on
December 1, 1999, in connection with the Merger of GoHealth.  This dismissal was
unrelated  to Jones,  Jensen's  competence,  practices  and  procedures.  Jones,
Jensen's  financial  statement  reports did not  contain  any  adverse  opinion,
disclaimer of opinion, or modified opinion.

         Jones,  Jensen has  informed  us that it will  provide the SEC a letter
containing  our position with the foregoing  statements  regarding our change in
certifying accountant.

                                   MANAGEMENT

                Directors, Executive Officers and Control Persons
               Name                   Age          Position(s) and Office(s)
- --------------------------------------------------------------------------------
      Dr. Leonard F. Vernon           44       President, Treasurer and Director
      William D. Hanna                54                    Director
      Kevin O'Donnell                 51                   Secretary

         DR. LEONARD F. VERNON, the  founder of  our only  subsidiary, GoHealth,
became our president,  treasurer and a director on November 10, 1999. Dr. Vernon
has managed and/or overseen the operation of a successful  private practice,  as
well as the  development  of a private  company  that  became a publicly  traded
NASDAQ  corporation.  Dr.  Vernon is 44 years old and has  maintained  a private
practice of  chiropractic  for over 20 years.  He was licensed by the New Jersey
State Board of Medical Examiners for the Practice of Chiropractic in New Jersey.
He is  additionally  licensed to practice  chiropractic in the State of Delaware
and the Commonwealth of Pennsylvania.

                                       11


<PAGE>





         WILLIAM D. HANNA became one of our directors and our vice  president on
November 10, 1999. Mr. Hanna  attended  Philadelphia  Community  College and has
extensive  experience  in real  estate  and site  development.  Previous  to his
retirement  more than five  years  ago,  Mr.  Hanna  worked  for 20 years in the
construction  industry as a steel erector and owner of his own business.  In the
past five  years,  Mr.  Hanna has  served as the chief  executive  officer  of a
durable medical  equipment company and has also been a co-owner of a provider of
discounted health care services to the general public.

         KEVIN  O'DONNELL  became one of our directors on November 10, 1999. Mr.
O'Donnell is a 1976 graduate of Rutgers  University  (B.A.  Political  Science).
From 1978 to 1996,  he was employed by  Burlington  Industries  as an operations
manager and then as Northeast Regional Sales and Marketing Manager. In 1990, Mr.
O'Donnell became the Director of Operations for Imaging  Management  Associates,
Inc.  In this  position,  he oversaw  the  project  development,  start-up,  and
operation of seven  outpatient  diagnostic  imaging  centers.  He has  extensive
experience in personnel recruitment, employee benefit programs,  supplier/vendor
networks,   and  contract  negotiation.   He  also  has  marketing  and  product
development  experience  in the  managed  care and  private  practice  physician
sectors of the healthcare marketplace.

BOARD OF DIRECTORS

         Directors  are  elected  to serve  until  the next  annual  meeting  of
stockholders  and until their  successors  have been elected and have qualified.
Officers  are  appointed  to serve until the  meeting of the Board of  Directors
following the next annual  meeting of  stockholders  and until their  successors
have been elected and have qualified.

         Our current  directors did not timely file required Forms 3 between the
time of their respective  appointments  until December 28, 1999.  Sandra Vernon,
the wife of one of our directors and our president, Dr. Leonard Vernon, acquired
more than 10% of our common stock in the  GoHealth  merger and filed a Form 3 on
December 28, 1999.

         Based solely upon our review of Forms 3, 4 and 5 and amendments thereto
furnished to the registrant under Rule 16a-3(a) during the fiscal year preceding
the filing of this Form  10-KSB,  we are not aware of any other person who was a
director,  officer,  or beneficial  owner of more than ten percent of our common
stock and who failed to file reports required by Section 16(a) of the Securities
Exchange Act of 1934 in a timely manner.

                             EXECUTIVE COMPENSATION

         The following  tables describe the compensation of the persons who have
served as the Company's chief executive  officer for the last three fiscal years
and since May 31, 1999.  No  compensation  in excess of $100,000 was awarded to,
earned by, or paid to any  executive  officer or director of the Company  during
the years ended May 31, 1999, 1998 or 1997, or has been since May 31, 1999.

                                       12


<PAGE>




                                                  Annual Compensation
          Name and           Fiscal                               Other Annual
     Principal Position       Year       Salary ($)   Bonus ($) Compensation ($)

       Dr. Leonard           1999         -0-(1)         -0-            -0-
          Vernon,
         President

       Tyson Schiff,         1999          -0-         $500(2)          -0-
         President

     Mary C. MacGuire,       1998          -0-           -0-            -0-
         President

     John W. MacGuire,       1997          -0-           -0-            -0-
         President


<TABLE>
<CAPTION>
                                                     Long Term Compensation
                                                   Awards                    Payouts
                                                   ------                    -------
                                          Restricted        Securities        LTIP         All Other
     Name and Principal     Fiscal           Stock          Underlying       Payouts     Compensation
          Position           Year         Award(s)($)     Options/SARs(#)      ($)            ($)
<S>                         <C>            <C>             <C>              <C>           <C>

        Dr. Leonard          1999             -0-               -0-            -0-
          Vernon,
         President

       Tyson Schiff,         1999             -0-               -0-            -0-            -0-
         President

       Mary C. MacGuire,     1998             -0-               -0-            -0-            -0-
         President

      John W. MacGuire,      1997             -0-               -0-            -0-            -0-
         President
</TABLE>

         (1)  Dr.  Leonard  Vernon  has  never  received  compensation  for  his
services.  However,  in the  event  our  revenues  exceed  $1,000,000  or at the
discretion of the board of  directors,  Dr. Vernon will receive an annual salary
of  approximately  $145,000.  At such point,  we also  expects to pay $75,000 to
Kevin O'Donnell, Vice President,  Director of Operations, and $30,000 to William
Hanna, President of Sales.

         (2) In October 1998,  Tyson Schiff received a $500 bonus for serving as
the  Company's  president  and  director  since July 1996,  and for  agreeing to
continue to serve as a director and the president of the Company.

                                       13


<PAGE>




            MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS

         Our common stock is currently traded through the NASD  Over-the-Counter
Bulletin Board  ("OTC-BB")  under the symbol NUGT.  Limited trading has occurred
over the past several years.

         In October 1998, our common stock experienced a 1-for-310 reverse stock
split  whereby each 310 shares was converted  into one share and all  fractional
shares  were  rounded  up.   Immediately   after  the  reverse  split,   we  had
approximately  97,177 total shares of issued and outstanding.  Simultaneous with
this  reverse  stock split the number of shares of common stock  authorized  for
issuance was reduced 1-for-10, from 50,000,000 to 5,000,000.

         At our 1999  annual  meeting,  held on August  16,  1999,  our Board of
Directors  and  the  holders  of a  majority  of the  outstanding  common  stock
increased the number of authorized shares of our common stock to 25,000,000 from
5,000,000.

         The  following  table set forth  below  lists the range of high and low
bids of our common stock for each fiscal  quarter for the last two fiscal years.
The prices in the table reflect  inter-dealer  prices,  without  retail  markup,
markdown or commission and may not represent actual transactions.

         The amounts,  and all other shares and price  information  contained in
this document have been adjusted to reflect the stock splits.

         FISCAL YEAR ENDED MAY 31, 1998            HIGH               LOW

                           First Quarter           $0.02             $0.005
                           Second Quarter          $0.02             $0.005
                           Third Quarter           $0.02             $0.001
                           Fourth Quarter          $0.02             $0.005

         FISCAL YEAR ENDED MAY 31, 1999

                           First Quarter           $0.02             $0.001
                           Second Quarter          $6.00             $0.062
                           Third Quarter           $7.00             $0.062
                           Fourth Quarter          $5.062            $0.062

         FISCAL YEAR ENDED MAY 31, 2000

                           First Quarter           $4.125            $1.375
                           Second Quarter          $5.25             $2.00
                           Third Quarter (*)       $5.812            $4.25

         * This is  only a  partial fiscal quarter as the third  quarter of 200
           began on December 1,

                                       14


<PAGE>



1999 and ends on  February  29,  2000.  The prices  listed in this  quarter  are
therefore high and low bids between December 1, 1999 through December 27, 1999.

         As of December 1, 1999, we had  approximately  4,099,603  shares of our
common stock outstanding held by approximately 622 holders of record.

                                    DIVIDENDS

         We have  never paid a cash  dividend  on our  common  stock.  It is our
present policy to retain earnings, if any, to finance the development and growth
of our business.  Accordingly, we do not anticipate declaring any cash dividends
in the foreseeable future.

                 CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

         Dr. Leonard Vernon  founded  GoHealth and is one of our directors,  our
president and the husband of Sandra Vernon, our largest shareholder.  Dr. Vernon
has a  previous  disciplinary  action by the New Jersey  State  Board of Medical
Examiners in which he was given an 18-month  suspension of his license,  30 days
of which were to be active with a monetary  penalty of $3000.  Dr. Vernon failed
to perform the required  community  service and pay the fine and the  suspension
was imposed for a full 18 months.  This disciplinary  action was taken after the
determination  that Dr. Vernon's  application to the  Educational  Commission of
Foreign Medical  Graduates was  misleading.  Dr. Vernon  currently  possesses an
unrestricted license to practice chiropractic in the State of New Jersey as well
and the  Commonwealth  of  Pennsylvania  and State of  Delaware  and there is no
pending  disciplinary  action  against  him in any of the  states in which he is
licensed.

         Our offices are  located at 2051  Springdale  Road,  Cherry  Hill,  New
Jersey,  which also houses the offices of Able  Imaging,  Inc.,  a wholly  owned
entity of  William D.  Hanna,  one of our  directors.  We do not pay rent to Mr.
Hanna for such facilities.

         We have obtained a total of $38,000  pursuant to three working  capital
loans from William  Hanna  Consultants,  Inc.,  an entity  controlled by William
Hanna,  one of our  directors.  All of these  notes are  unsecured,  require all
interest and principal be repaid in one lump sum and bear 5% interest per annum.
A $25,000  April 26,  1999  Note was due to be repaid on May 26,  1999,  and was
extended  indefinitely.  No  additional  consideration  was  tendered  for  this
indefinite extension.  A $10,000 Note dated March 29, 1999, matures on March 29,
2000. A $3,000 Note dated May 2, 1999  matures on May 2, 2000.  We have not made
any payments of interest or principal upon either the March 29, 1999 Note or the
May 2, 1999 Note.

         Ken Kurtz currently owns less than 5% of our outstanding  common stock.
Prior to the GoHealth merger,  however,  he owned in excess of 50% of the common
stock.  Mr.  Kurtz  received  400,000  shares  pursuant  to a November  30, 1998
consulting agreement with us whereby he agreed to assist in preparing employment
agreements, contracts and other filings required by the Commission and all other
necessary  state  and  Federal  regulatory  bodies,  and in  referring  to us an
independent auditor and attorney.

                                       15


<PAGE>



         On June  22,  1998,  for a  $15,100  investment  we  issued  15,100,000
restricted shares of common stock (the "Shares") to a designee of Park Street --
First Avenue, Ltd., a limited partnership  organized under the laws of the State
of Utah.  Ken Kurtz,  being a general  partner  of First  Avenue,  Ltd.  and the
president of Park Street, indirectly controls such shares.

         According to a Financial  Consulting Agreement between Company and Park
Street  Investments,  Inc.  executed on March 5, 1998, Park Street assisted with
our  administration  and  recapitalization.  Park Street also agreed to actively
pursue and negotiate a merger or business  combination with a third party on our
behalf.  GoHealth  was  introduced  to us through  the efforts of Kurtz and Park
Street.  Park  Street  paid all costs  associated  with  these  responsibilities
through the GoHealth merger.

                        UNDERTAKING REGARDING FORM 10-KSB

         We hereby  undertake to provide without charge to each person solicited
with this proxy statement,  on the written request of any such person, a copy of
its annual  report on Form 10-KSB  including the  financial  statements  and the
financial  statement  schedules,  required to be filed with the  Securities  and
Exchange  Commission  pursuant  to Rule 13a-1  under the Act for the fiscal year
ended May 31, 1999.

         This written  request should be addressed to us at our  headquarters at
2051 Springdale Road, Cherry Hill, New Jersey 08003.

                                    SIGNATURE

By order of the board of directors,


 /s/ Dr. Leonard Vernon
- ----------------------------------
Dr. Leonard Vernon, President

Cherry Hill, New Jersey
December 29, 1999

                                       16


<PAGE>




                                INDEX TO EXHIBITS

EXHIBIT
  NO.             DESCRIPTION

2.1      Stock Exchange  Agreement and  Plan of Merger dated September 30, 1999,
         by and between  Nugget  Exploration, Inc.,  Nugget  Holding Company and
         GoHealth.MD,  Inc.  Incorporated herein  from  our Form  10-QSB for the
         quarter ended August 31, 1999.

23.1     Consent of Jones, Jensen & Co.

23.2     Consent of Samuel Klein & Co.


                                       17


<PAGE>

                [SEE END OF DOCUMENT FOR EXHIBITS 23.1 AND 23.2]

<PAGE>









                            NUGGET EXPLORATION, INC.
                          (A DEVELOPMENT STAGE COMPANY)

                              FINANCIAL STATEMENTS

                              MAY 31, 1999 AND 1998







                                       20


<PAGE>







                                    CONTENTS

Independent Auditors' Report..................................................22

Balance Sheets................................................................23

Statements of Operations......................................................24

Statements of Stockholders' Equity (Deficit)..................................25

Statements of Cash Flows......................................................27

Notes to the Financial Statements.............................................29





                                       21


<PAGE>



                    [Letterhead of Jones, Jensen & Company]



                          INDEPENDENT AUDITORS' REPORT

Board of Directors
Nugget Exploration, Inc.
(A Development Stage Company)
Casper, Wyoming

We have audited the accompanying  balance sheets of Nugget Exploration,  Inc. (a
development  stage  company)  as of May 31,  1999  and  1998,  and  the  related
statements of operations, stockholders' equity (deficit), and cash flows for the
years  ended May 31,  1999,  1998 and 1997 and from  inception  on July 24, 1980
through May 31, 1999. These financial  statements are the  responsibility of the
Company's  management.  Our  responsibility  is to  express  an opinion on these
financial statements based on our audits.

We  conducted  our  audits  in  accordance  with  generally   accepted  auditing
standards. Those standards require that we plan and perform the audits to obtain
reasonable assurance about whether the financial statements are free of material
misstatement.  An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements.  An audit also includes
assessing the  accounting  principles  used and  significant  estimates  made by
management,  as well as evaluating the overall financial statement presentation.
We believe that our audits provide a reasonable basis for our opinion.

In our opinion,  the financial  statements  referred to above present fairly, in
all material  respects,  the financial position of Nugget  Exploration,  Inc. (a
development  stage  company) as of May 31, 1999 and 1998, and the results of its
operations  and its cash flows for the years ended May 31,  1999,  1998 and 1997
and from  inception  on July 24, 1980  through May 31, 1999 in  conformity  with
generally accepted accounting principles.

The  accompanying  financial  statements  have been  prepared  assuming that the
Company  will  continue  as a  going  concern.  As  discussed  in  Note 2 to the
financial statements, the Company's recurring losses from operations and working
capital deficit raise substantial doubt about its ability to continue as a going
concern.  Management's plans concerning these matters are also described in Note
2. The  financial  statements do not include any  adjustments  that might result
from the outcome of this uncertainty.

/s/ Jones, Jensen & Company

Jones, Jensen & Company
Salt Lake City, Utah

July 21, 1999


              The accompanying notes are an integral part of these
                             financial statements.



                                       22


<PAGE>


<TABLE>
<CAPTION>
                                           NUGGET EXPLORATION, INC.
                                           (A Development Stage Company)
                                                  Balance Sheets

                                                      ASSETS

                                                                             MAY 31,
                                                                   1999                 1998
                                                                   ----                 ----
CURRENT ASSETS
<S>                                                         <C>                  <C>

   Cash                                                      $           6,180   $             7,010
                                                             -----------------   -------------------
     Total Current Assets                                                6,180                 7,010
                                                             -----------------   -------------------
OTHER ASSETS

   Patented lode mining claims held for sale (Note 4)                   -                    111,502
                                                             -----------------   -------------------
     Total other assets                                                 -                    111,502
                                                             -----------------   -------------------
     TOTAL ASSETS                                            $           6,180   $           118,512
                                                             =================   ===================

</TABLE>

<TABLE>
<CAPTION>

                                  LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
                                  ----------------------------------------------

CURRENT LIABILITIES
<S>                                                          <C>                 <C>
   Accounts payable                                          $          20,465   $           147,553
   Accrued payroll - related party (Note 5)                             -                    651,389
   Notes payable - related parties (Note 3)                             -                    624,642
   Accrued interest - related parties (Note 3)                          -                    591,652
   Notes payable (Note 6)                                                7,380                29,714
   Accrued interest (Note 6)                                             8,702                27,635
                                                             -----------------   -------------------
     TOTAL CURRENT LIABILITIES                                          36,547             2,072,585
                                                             -----------------   -------------------
     TOTAL LIABILITIES                                                  36,547             2,072,585
                                                             -----------------   -------------------


STOCKHOLDERS' EQUITY (DEFICIT)

   Common stock: 50,000,000 shares authorized
    of $0.01 par value; 697,117 and 48,407
    shares issued and outstanding, respectively                          6,971                   484
   Additional paid-in capital                                        3,536,930             3,342,317
   Deficit accumulated during the development stage                 (3,574,268)           (5,296,874)
                                                             -----------------   -------------------
     Total Stockholders' Equity (Deficit)                              (30,367)           (1,954,073)
                                                             -----------------   -------------------
     TOTAL LIABILITIES AND STOCKHOLDERS'
      EQUITY (DEFICIT)                                       $           6,180   $           118,512
                                                             =================   ===================
</TABLE>

                           The accompanying notes are an integral part of these
                                          financial statements.

                                                                 23


<PAGE>


<TABLE>
<CAPTION>
                                             NUGGET EXPLORATION, INC.

                                           (A Development Stage Company)
                                             Statements of Operations


                                                                                                           From
                                                                                                       Inception on
                                                                                                         July 24,
                                                                   For the Years Ended                 1980 Through
                                                                        May 31,                           May 31,

                                                1999                1998                1997               1999
                                          ----------------  ------------------   -----------------  -------------------
<S>                                       <C>               <C>                 <C>                <C>
REVENUES                                  $         -       $           -        $          -       $            -
                                          ----------------  ------------------   -----------------  -------------------
EXPENSES                                           250,304              78,524              78,967            5,547,178
                                          ----------------  ------------------   -----------------  -------------------
NET LOSS FROM OPERATIONS                          (250,304)            (78,524)            (78,967)          (5,547,178)
                                          ----------------  ------------------   -----------------  -------------------
OTHER INCOME

   Gain on sale of asset (Note 4)                  588,499              -                   -                   588,499
                                          ----------------  ------------------   -----------------  -------------------
     Total Other Income                            588,499              -                   -                   588,499
                                          ----------------  ------------------   -----------------  -------------------
NET INCOME (LOSS) BEFORE

 EXTRAORDINARY ITEM                                338,195             (78,524)            (78,967)          (4,958,679)
                                          ----------------  ------------------   -----------------  -------------------
EXTRAORDINARY ITEM (Note 7)

   Gain on extinguishment of debt                1,384,411              -                   -                 1,384,411
                                          ----------------  ------------------   -----------------  -------------------
     Total Extraordinary Item                    1,384,411              -                   -                 1,384,411
                                          ----------------  ------------------   -----------------  -------------------
NET INCOME (LOSS)                         $      1,722,606  $          (78,524)  $         (78,967) $        (3,574,268)
                                          ================  ==================   =================  ===================
BASIC INCOME (LOSS) PER
 SHARE OF COMMON STOCK

   Before extraordinary items             $           0.85  $            (1.62)  $           (1.63)
   Extraordinary items                                3.50              -                   -
                                          ----------------  ------------------   -----------------
     Basic Income (Loss) Per

      Share of Common Stock               $           4.35  $            (1.62)  $           (1.63)
                                          ================  ==================   =================
WEIGHTED AVERAGE NUMBER
 OF SHARES OUTSTANDING                             396,162              48,407              48,407
                                          ================  ==================   =================
</TABLE>


                            The accompanying notes are an integral part of these
                                             financial statements.

                                                       24


<PAGE>


<TABLE>
<CAPTION>
                                                NUGGET EXPLORATION, INC.

                                              (A Development Stage Company)
                                      Statements of Stockholders' Equity (Deficit)


                                                                                                  Deficit
                                                                                                 Accumulated
                                                                                Additional        During the
                                                             Common Stock        Paid-in        Development
                                                 Shares         Amount           Capital            Stage
<S>                                           <C>              <C>            <C>             <C>
At inception on July 24, 1980                      -               $-               $-             $   -

Common stock issued for property
 at approximately $19.62 per share              10,452           104             204,940               -

Common stock issued for cash
 at approximately $30.33 per share               2,374            24              71,976               -

Common stock issued for cash
 at approximately $77.50 per share               9,677            97             749,903               -

Stock offering costs                               -              -              (18,854)              -

Common stock issued for cash
 at approximately $77.52 per share                 258             3              19,997               -

Common stock issued for cash
 at approximately $96.68 per share              16,129           161           2,499,839               -

Stock offering costs                               -              -             (482,517)              -

Stock issued for property
 at approximately $96.68 per share               2,581            26             249,502               -

Warrant issued for cash                            -              -                  100               -

Common stock issued for cash
 and services at approximately
 $43.41 per share                                  645             6              27,994               -

Common stock issued for services
 at approximately$3.10 per share                   323             3                 997               -

Common stock issued for debt
 at approximately $3.10 per share                5,968            60              18,440               -

Net loss for the period from
 inception on July 24, 1980 to
 May 31, 1995                                      -               -                 -             (5,103,532)
                                          ------------------  -----------    -------------    -------------------
Balance, May 31, 1995                           48,407           484           3,342,317           (5,103,532)

Net loss for the year ended

 MAY 31, 1996                                      -                -                   -             (35,851)
                                          ------------------  -----------    -------------    -------------------
Balance, May 31, 1996                           48,407        $  484         $ 3,342,317          $(5,139,383)
                                          ------------------  -----------    -------------    --------------------
</TABLE>

                           The accompanying notes are an integral part of these
                                          financial statements.

                                                   25


<PAGE>




<TABLE>
<CAPTION>
                                                NUGGET EXPLORATION, INC.

                                              (A Development Stage Company)
                                Statements of Stockholders' Equity (Deficit) (Continued)



                                                                                                     Deficit
                                                                                                   Accumulated
                                                                              Additional            During the
                                                     Common Stock              Paid-in             Development
                                              Shares            Amount         Capital                Stage
                                              ------            ------         -------                -----
<S>                                       <C>            <C>               <C>                 <C>
Balance, May 31, 1996                           48,407    $      484        $  3,342,317        $  (5,139,383)

Net loss for the year ended
 May 31, 1997                                      -               -                   -              (78,967)
                                          --------------  ---------------   -----------------  --------------------
Balance, May 31, 1997                           48,407           484           3,342,317           (5,218,350)

Net loss for the year ended
 May 31, 1998                                      -              -                   -               (78,524)
                                          --------------  ---------------   -----------------  --------------------
Balance, May 31, 1998                           48,407           484           3,342,317           (5,296,874)

Common stock issued for cash
$0.31 per share                                 48,710           487              14,613                -

Common stock issued for services
 at $0.31 per share                            600,000         6,000             180,000                -

Net income for the year ended
 May 31, 1999                                     -               -                   -             1,722,606
                                          --------------  ---------------   -----------------  --------------------
Balance, May 31, 1999                          697,117    $    6,971   $    $  3,536,930        $  (3,574,268)
                                          ==============  ===============   =================  ====================
</TABLE>




                           The accompanying notes are an integral part of these
                                               financial statements.

                                                       26


<PAGE>


<TABLE>
<CAPTION>
                                              NUGGET EXPLORATION, INC.

                                           (A Development Stage Company)
                                              Statements of Cash Flows


                                                                                                            From
                                                                                                         Inception on
                                                                                                          July 24,
                                                                 For the Years Ended                    1980 Through
                                                                         May 31,                            May 31,
                                                        1999              1998             1997              1999
                                                    --------------   ---------------  ---------------   ------------------
<S>                                                <C>              <C>              <C>                 <C>
CASH FLOWS FROM
 OPERATING ACTIVITIES:

   Net income (loss)                                $    1,722,606   $   (78,524)     $    (78,967)       $  (3,574,268)
   Adjustments to reconcile net loss to
    changes in operating assets and
    liabilities:
     Stock issued for services, property and
         debt                                              186,000            -                -                550,571
     Gain on sale of asset                                (588,499)           -                -               (588,499)
     Gain on extinguishment of debt                     (1,384,411)           -                -             (1,384,411)
   Changes in operating assets and liabilities:
     Increase (decrease) in accrued expenses                   664        74,709            73,907            1,271,340
     Increase (decrease) in accounts payable               (90,611)       10,803             4,932               56,942
                                                      -------------   ------------    -------------       --------------
       Net Cash Provided (Used) by
        Operating Activities                              (154,251)        6,988              (128)          (3,668,325)
                                                      -------------   ------------    -------------       --------------

CASH FLOWS FROM
 INVESTING ACTIVITIES:

   Investment in property                                     -               -                -               (111,502)
   Cash received on sale of property                       700,000            -                -                700,000
                                                      ------------    ------------    -------------       --------------
       Net Cash Provided by
        Investing ActivitieS                               700,000            -                -                588,498
                                                      ------------    ------------    -------------       --------------
CASH FLOWS FROM
 FINANCING ACTIVITIES:

   Sale of common stock for cash - net of
     stock offering costs                                   15,100            -                -              2,993,330
   Cash payments of notes payable - related               (561,679)           -                -               (561,679)
   Proceeds from notes payable                              -                 -                -                654,356
                                                      ------------    ------------    -------------       --------------

       Net Cash Provided (Used) by
        Financing Activities                              (546,579)           -                -              3,086,007
                                                      ------------    ------------    -------------       --------------
INCREASE (DECREASE) IN CASH
 AND CASH EQUIVALENTS                                         (830)        6,988              (128)              6,180

CASH AND CASH EQUIVALENTS AT

 BEGINNING OF PERIOD                                         7,010            22               150                -
                                                      ------------    ------------    -------------       --------------
CASH AND CASH EQUIVALENTS AT

 END OF PERIOD                                        $      6,180    $     7,010     $         22        $        6,180
                                                      ============    ============    ==============      ==============
</TABLE>


                    The  accompanying  notes  are  an  integral  part  of  these
                                            financial statements.

                                                     27


<PAGE>


<TABLE>
<CAPTION>
                                                  NUGGET EXPLORATION, INC.

                                                (A Development Stage Company)
                                             Statements of Cash Flows (Continued)


                                                                                                              From
                                                                                                          Inception on
                                                                                                           July 24,
                                                                   For the Years Ended                   1980 Through
                                                                         May 31,                            May 31,
                                                        1999              1998             1997               1999
                                                    --------------   ---------------  ---------------   ------------------
<S>                                                 <C>             <C>               <C>             <C>
SUPPLEMENTAL CASH FLOW
 INFORMATION

CASH PAID FOR:

   Interest                                         $       -        $    -           $      -           $           -
   Income taxes                                     $       -        $    -           $      -           $           -

NON-CASH FINANCING ACTIVITIES

   Common stock issued for services rendered        $   186,000      $    -           $      -            $    200,000
   Common stock issued for debt relief              $       -        $    -           $      -            $     18,500
   Common stock issued for property                 $       -        $    -           $      -            $    249,528

</TABLE>

                    The  accompanying  notes  are  an  integral  part  of  these
                                       financial statements.

                                                28


<PAGE>



                            NUGGET EXPLORATION, INC.

                          (A Development Stage Company)
                        Notes to the Financial Statements

                              May 31, 1999 and 1998



NOTE 1 -      ORGANIZATION AND HISTORY

              Nugget Exploration,  Inc. (the Company) was incorporated under the
              laws of Nevada on July 24, 1980 for the purpose of  exploring  for
              and developing  uranium,  gold and other mineral  properties.  The
              Company has had limited operations to date and its activities have
              consisted  primarily of raising equity capital and the acquisition
              and exploration of mineral properties; accordingly, the Company is
              considered to be a development stage enterprise as defined in SFAS
              7.  Current  operations  are being funded by  borrowings  from the
              Company's officers.

              a.  Accounting Method

              The Company's financial  statements are prepared using the accrual
              method of  accounting.  The  Company has elected a May 31 calendar
              year end.

              b.  Cash and Cash Equivalents

              Cash equivalents  include  short-term,  highly liquid  investments
              with   maturities   of  three  months  or  less  at  the  time  of
              acquisition.

              c.  Basic Loss Per Share

              The computations of basic loss per share of common stock are based
              on the weighted  average number of shares  outstanding  during the
              period of the financial statements.

              d.  Provision for Taxes

              At May 31, 1999, the Company had net operating loss  carryforwards
              of  approximately  $3,500,000  that may be offset  against  future
              taxable  income  through 2014. No tax benefit has been reported in
              the financial statements,  because the Company believes there is a
              50% or  greater  chance  the  carryforwards  will  expire  unused.
              Accordingly,  the potential tax benefits of the loss carryforwards
              are offset by a valuation allowance of the same amounts.

              e.  Estimates

              The  preparation  of  financial   statements  in  conformity  with
              generally accepted  accounting  principles  requires management to
              make estimates and assumptions that affect the reported amounts of
              assets and  liabilities  and  disclosure of contingent  assets and
              liabilities  at the  date  of the  financial  statements  and  the
              reported  amounts of revenues  and expenses  during the  reporting
              period. Actual results could differ from those estimates.

                                       29


<PAGE>



                            NUGGET EXPLORATION, INC.

                          (A Development Stage Company)
                        Notes to the Financial Statements

                              May 31, 1999 and 1998



NOTE 2 -      GOING CONCERN

              The Company's  financial  statements are prepared using  generally
              accepted accounting principles applicable to a going concern which
              contemplates   the   realization  of  assets  and  liquidation  of
              liabilities in the normal course of business. However, the Company
              does not have significant cash or other material assets,  nor does
              it have an established source of revenues  sufficient to cover its
              operating costs and to allow it to continue as a going concern. It
              is the intent of the  Company to seek a merger  with an  existing,
              operating  company.  Until that time,  shareholders of the Company
              have committed to meeting its minimal operating needs.

NOTE 3 -      NOTES PAYABLE - RELATED PARTIES

<TABLE>
<CAPTION>

              Notes payable - related parties at May 31, 1999 and 1998 consisted
              of the following:

                                                                      1999                  1998
                                                                -----------------     -----------------
<S>                                                              <C>                    <C>
              Note payable to officers of the Company,
               interest at 12% per annum, due on demand,
               unsecured.                                         $      -              $     155,203

              Notes payable to an officer of the Company,
               interest at 11% to 12.75%, due on demand,
               unsecured.                                                -                    434,073

              Note payable to a related party bearing interest
               at 2% over prime, due on demand, unsecured.               -                     34,166

              Note payable to a related party bearing interest
               at 2% over prime, due on demand, unsecured.               -                      1,200
                                                                  --------              --------------
                   Totals                                                -                    624,642

                   ACCRUED INTEREST                                      -                    591,652
                                                                  ---------------       ---------------
                   TOTAL AMOUNTS DUE                              $      -              $    1,216,294
                                                                  ===============       ===============
</TABLE>

              Since inception of the Company, the President and Treasurer of the
              Company had advanced money to the Company  without  collateral and
              paid  certain  expenses on behalf of the  Company,  which  totaled
              $624,642 at May 31, 1998.  During the year ended May 31, 1999, the
              Company  settled the amount in full,  including  accrued  interest
              thereon.

                                       30


<PAGE>



                            NUGGET EXPLORATION, INC.

                          (A Development Stage Company)
                        Notes to the Financial Statements

                              May 31, 1999 and 1998

NOTE 4 -      PATENTED LODE MINING CLAIMS SALE

              The Company acquired patented lode mining claims in Atlantic City,
              Wyoming for the purpose of mining gold.  During the year ended May
              31, 1999, the mining claims were sold at a gain of $588,499.

NOTE 5 -      ACCRUED PAYROLL - RELATED PARTY

              The Company had accrued salary to the Company's former  President.
              At May 31, 1999 and 1998,  the amounts due were $-0- and $651,389,
              respectively.

NOTE 6 -      NOTES PAYABLE

              Notes payable at May 31, 1999 and 1998 consisted of the following:
<TABLE>
<CAPTION>

                                                                        1999                  1998
                                                                 -----------------     -----------------
<S>                                                               <C>                  <C>
              Note payable to an individual, interest at 9%
               per annum, due on demand, unsecured.               $     2,290                $2,290

              Note payable to an individual, interest at 9%
               per annum, due on demand, unsecured.                     5,090                 5,090

              Notes payable to a company, interest at 10.5% -
               12.75%, due on demand, unsecured.                          -                  22,334
                                                                  -------------        -----------------
                   Totals                                               7,380                29,714

                   Accrued interest                                     8,702                27,635
                                                                  -------------        -----------------
                   Total Amounts Due                              $    16,082          $     57,349
                                                                  =============        =================
</TABLE>



                                       31


<PAGE>



                            NUGGET EXPLORATION, INC.

                          (A Development Stage Company)
                        Notes to the Financial Statements

                              May 31, 1999 and 1998

NOTE 7 -      EXTRAORDINARY ITEM

              During the year ended May 31, 1999, the Company  recognized a gain
              from  extinguishment  of debt in the  amount of  $1,384,411.  FASB
              Statement No. 4 requires that gains and losses from extinguishment
              of debt be reported as  extraordinary  items. Due to the Company's
              net operating loss  carryforwards,  tax effects are not considered
              in the  calculation.  The  gain  on  extinguishment  of  debt  was
              calculated as follows:
<TABLE>
<CAPTION>

                                            Balance,                     Gain on Debt                  Balance,
                                            May 31,         Cash         Extinguish-                    May 31,
                                            1998             Payments      ments         Additions       1999
                                         -------------  -------------  --------------  -----------  --------------
<S>                                     <C>             <C>             <C>             <C>          <C>

              Accounts payable           $     147,553  $     (92,342)  $     (36,476)  $   1,730    $   20,465
              Accrued payroll -
                related party                  651,389         -             (651,389)        -             -
              Notes payable -
                related parties                624,642       (561,679)        (62,963)        -             -
              Accrued interest -
                related parties                591,652         -             (591,652)        -             -
              Notes payable                     29,714         -              (22,334)        -           7,380
              ACCRUED INTEREST                  27,635         -              (19,597)        664         8,702
                                         -------------  -------------   -------------   ----------   -------------
              TOTAL                      $   2,072,585  $    (654,021)  $  (1,384,411)  $   2,394    $   36,547
                                         =============  =============   =============   ==========   =============
</TABLE>


                                       32


<PAGE>







                                GOHEALTH.MD, INC.
                          (A DEVELOPMENT STAGE COMPANY)

                              FINANCIAL STATEMENTS

                               SEPTEMBER 30, 1999







                                       33


<PAGE>


                    [Letterhead of Samuel Klein and Company]






                          INDEPENDENT AUDITOR'S REPORT


To the Board of Directors of
GOHEALTH.MD, Inc.
(A Development Stage Company)
Cherry Hill, New Jersey 08003

We  have  audited  the  accompanying  balance  sheet  of  GOHEALTH.MD,  Inc.  (A
Development  Stage Company) as of September 30, 1999 and the related  statements
of operations, stockholders= equity and cash flows for the period from inception
(February 23, 1999) to September 30, 1999.  These  financial  statements are the
responsibility of the Company's management.  Our responsibility is to express an
opinion on these financial statements based on our audit.

We conducted our audit in accordance with generally accepted auditing standards.
Those standards  require that we plan and perform the audit to obtain reasonable
assurance   about  whether  the  financial   statements  are  free  of  material
misstatement.  An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements.  An audit also includes
assessing the  accounting  principles  used and  significant  estimates  made by
management, as well as evaluating the overall financial statement presentation.

We believe that our audit provides a reasonable basis for our opinion.

In our opinion,  the financial  statements  referred to above present fairly, in
all  material  respects,   the  financial  position  of  GOHEALTH.MD,   Inc.  (A
Development  Stage  Company)  as of  September  30,  1999 and the results of its
operations  and its cash flows for the initial  period then ended in  conformity
with generally accepted accounting principles.

                                                         /S/
                                                       SAMUEL KLEIN AND COMPANY

Newark, New Jersey
December 27, 1999



                                       34


<PAGE>



                                GOHEALTH.MD, INC.
                          (A DEVELOPMENT STAGE COMPANY)

                                  BALANCE SHEET

                               SEPTEMBER 30, 1999

ASSETS

Current Assets:

   Cash                                                          $109,016
   Accounts receivable                                                 48
   Stock subscription receivable                                    1,400
   Domain names - available for sale                               27,577
                                                               ----------
                                                                  138,041

Other Assets:

   Website costs                                                   65,955

                                                                 $203,996

LIABILITIES AND STOCKHOLDERS' EQUITY
- ------------------------------------

Current Liabilities:

   Accounts payable                                              $ 37,806
   Accrued expenses                                                 4,694
   Notes payable                                                   38,000
   Due to officer                                                  21,622
                                                               ----------
          Total Liabilities                                       102,122

Stockholders' Equity:

   Common stock ($.001 par value, 10,000,000 shares
     authorized, 3,080,000 shares issued and outstanding)           3,080
   Additional paid-in capital                                     207,920
   Deficit accumulated during the development stage             (109,126)
                                                               ----------
          Total Stockholders' Equity                              101,874

                                                                 $203,996
                                                               ===========
- --------------------

The accompanying notes are an integral part of these financial statements.

                                       35


<PAGE>



                                GOHEALTH.MD, INC.
                          (A DEVELOPMENT STAGE COMPANY)

                             STATEMENT OF OPERATIONS

                FOR THE PERIOD FROM INCEPTION (FEBRUARY 23, 1999)

                              TO SEPTEMBER 30, 1999



Sales:

   Advertising revenue                                            $           48
   Domain name sales                                                       1,300
Cost of Sales                                                              (910)
         Gross Profit                                                        438

Other Expenses:

   General and administrative expenses                                    82,532
   Marketing and licensing fees                                           26,338
   Interest expensE                                                          694
                                                                  --------------
                                                                         109,564
                                                                  --------------
Net Loss                                                              $(109,126)
                                                                  ==============

- --------------------

The accompanying notes are an integral part of these financial statements.

                                       36


<PAGE>



                                GOHEALTH.MD, INC.
                          (A DEVELOPMENT STAGE COMPANY)

                        STATEMENT OF STOCKHOLDERS' EQUITY

                FOR THE PERIOD FROM INCEPTION (FEBRUARY 23, 1999)

                              TO SEPTEMBER 30, 1999


<TABLE>
<CAPTION>

                                                                                            Deficit
                                                     Common Stock                          Accumulated
                                                   $.001 Par Value          Additional      During the          Total
                                              Number                          Paid-In      Development      Stockholders'
                                            of Shares         Amount          Capital          Stage            Equity
                                            ---------        ---------      ------------   -------------    --------------
<S>                                        <C>             <C>              <C>            <C>              <C>
At Inception on February 23, 1999 $                           $              $              $               $

Issuance of Common Stock
 at $.001 per share                         3,000,000           3,000           -               -                 3,000

Issuance of Shares and Warrants
 in Private Placement                          76,000              76         197,524           -               197,600

Issuance of Shares and
 Warrants for Services                          4,000               4          10,396           -                10,400

Net Loss for the Period from
 Inception February 23, 1999 to
   September 30, 1999                                                                         (109,126)        (109,126)
                                          -------------    ------------     ------------    ------------     -------------
                                          $ 3,080,000       $   3,080        $ 207,920      $ (109,126)     $   101,874
                                          =============    ============     ============    ============     ============
</TABLE>









- --------------------

The accompanying notes are an integral part of these financial statements.

                                                          37


<PAGE>



                                GOHEALTH.MD, INC.
                          (A DEVELOPMENT STAGE COMPANY)

                             STATEMENT OF CASH FLOWS

                FOR THE PERIOD FROM INCEPTION (FEBRUARY 23, 1999)

                              TO SEPTEMBER 30, 1999



Cash Flows from Operating Activities:

   Net loss                                                           $(109,126)
   Adjustment to reconcile net loss to net cash
     used in operating activities:
       Increase in accounts receivable                                      (48)
       Increase in stock subscription receivable                         (1,400)
       Increase in Domain names - available for sale                    (27,577)
       Increase in accounts payable                                      37,806
       Increase in accrued expenses                                       4,694
                                                                     -----------
          Net cash used in operating activities                         (95,651)
                                                                     ----------

Cash Flows from Investing Activities:
   Purchase of Website                                                  (55,555)
          Net cash used in investing activities                         (55,555)

Cash Flows from Financing Activities:
   Proceeds from sale of common stock and stock warrants                200,600
   Proceeds of notes payable                                             38,000
   Proceeds from officers loans                                          21,622
                                                                     -----------
          Net cash provided by investing activities                     260,222
                                                                     -----------
Net Increase in Cash                                                    109,016

Cash - Inception (February 23, 1999)                                  $     -
                                                                            -
                                                                     -----------
Cash - End of Period (September 30, 1999)                              $109,016
                                                                     ===========

Supplemental Disclosures of Cash Flow Information:
   Cash paid during the period for:
     Interest                                                         $     -
     Taxes                                                            $     -
                                                                     ===========

Supplemental Disclosure of Noncash Investing
 and Financing Activities:
     Issuance of common stock and warrants for
      Website purchase                                                $  10,400
                                                                     ===========


- --------------------

The accompanying notes are an integral part of these financial statements.

                                                          38


<PAGE>



                                GOHEALTH.MD, INC.
                          (A DEVELOPMENT STAGE COMPANY)

                          NOTES TO FINANCIAL STATEMENTS

                               SEPTEMBER 30, 1999

1.  THE COMPANY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NATURE OF BUSINESS

GOHEALTH.MD, Inc. (the ACompany@), a development stage company, was incorporated
under the laws of the State of Delaware on February 23, 1999. GOHEALTH.MD,  Inc.
will be engaged in  providing  through the Internet an  advertising  network and
Internet  presence  for  independently-owned  health  food  stores,  health care
providers and others.

BASIS OF ACCOUNTING

The financial  statements of the Company have been prepared on the accrual basis
of accounting.

CASH AND CASH EQUIVALENTS

The Company  considers  all highly liquid  investments  with a maturity of three
months or less to be cash equivalents.

USE OF MANAGEMENT'S ESTIMATES

The preparation of financial  statements in conformity  with generally  accepted
accounting principles requires management to make estimates and assumptions that
affect  the  reported  amounts  of assets  and  liabilities  and  disclosure  of
contingent assets and liabilities as of the date of the financial statements and
the reported amounts of revenues and expenses during the reported period. Actual
results could differ from those estimates.

DOMAIN NAMES - AVAILABLE FOR SALE

Domain name - available for sale consists of specific domain names purchased and
are valued at the purchase price. When a domain name is sold, the purchase price
for that specific name is removed at cost.

IMPAIRMENT OF LONG-LIVED ASSETS

The Company adopted  Statement of Financial  Accounting  Standards No. 121 (SFAS
121),  "Accounting  for the  Impairment of Long-Lived  Assets and for Long-Lived
Assets to be Disposed  of".  SFAS 121 requires  that if facts and  circumstances
indicate  that the cost of fixed  assets  or othe  assets  may be  impaired,  an
evaluation  of  recoverability  would be performed by  comparing  the  estimated
future undiscounted  pre-tax cash flows associated with the asset to the asset's
carrying  value to  determine  if a  write-down  to market  value or  discounted
pre-tax cash flow value would be required.

ADVERTISING AND PROMOTIONAL COSTS

Advertising  expenditures of the Company's programs and services are expensed in
the period the advertising costs are incurred. Advertising and promotional costs
for the period from  inception  (February  23, 1999) to September  30, 1999 were
$24,478.

                                       39


<PAGE>



                                GOHEALTH.MD, INC.
                          (A DEVELOPMENT STAGE COMPANY)

                          NOTES TO FINANCIAL STATEMENTS

                               SEPTEMBER 30, 1999

                                   (Continued)

1.  THE COMPANY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
    COMPREHENSIVE INCOME

The Company adopted Statement of Financial  Accounting  Standards No. 130, (SFAS
130) AReporting  Comprehensive Income@. This statement establishes rules for the
reporting of comprehensive  income and its components which require that certain
items such as foreign  currency  translation  adjustments,  unrealized gains and
losses on certain  investments in debt and equity  securities,  minimum  pension
liability  adjustments  and  unearned  compensation  expense  related  to  stock
issuances to employees be  presented  as separate  components  of  stockholders=
equity. The adoption of SFAS 130 had no impact on total stockholders= equity for
the period presented in these financial statements.

START-UP ACTIVITIES

The American Institute of Certified Public Accountants recently issued Statement
of Position ("SOP") 98-5, "Reporting the Costs of Start-Up Activities." SOP 98-5
requires start-up costs, as defined, to be expensed as incurred and is effective
for financial  statements  for fiscal years after December 15, 1998. The Company
currently  expenses all start-up  costs as incurred and the  application  of SOP
98-5 will have no material impact on the Company's financial statements.

STOCK-BASED COMPENSATION

The Company has elected to follow  Accounting  Principles  Board Opinion No. 25,
(APB 25)  "Accounting  for Stock  Issued to  Employees"  in  accounting  for its
employee  stock  option  plans.  Under APB 25,  when the  exercise  price of the
Company's  employee  stock  options  equals or is above the market  price of the
underlying stock on the date of grant, no compensation expense is recognized.

In  accounting  for  options  granted  to  persons  other  than  employees,  the
provisions of Financial Accounting Standards Board Statement No. 123, (FASB 123)
"Accounting for Stock Based  Compensation" are applied.  In accordance with FASB
123 the fair value of these  options are to be estimated at the grant date using
the Black- Scholes option pricing model.

INCOME TAXES

The Company follows Statement of Financial  Accounting  Standards No. 109, (SFAS
109)  "Accounting  for Income  Taxes".  SFAS 109  requires  the  recognition  of
deferred tax liabilities and assets for the expected future tax  consequences of
events that have been included in the financial statements or tax returns. Under
this method,  deferred tax  liabilities  and assets are determined  based on the
difference  between the financial  statement  carrying  amounts and tax bases of
assets and  liabilities  using enacted tax rates in effect in the years in which
the  differences are expected to reverse.  Valuation  allowances are established
when  necessary  to reduce  deferred  tax  assets to the amount  expected  to be
realized.

                                       40


<PAGE>



                                GOHEALTH.MD, INC.
                          (A DEVELOPMENT STAGE COMPANY)

                          NOTES TO FINANCIAL STATEMENTS

                               SEPTEMBER 30, 1999

                                   (Continued)


2.  PLAN OF OPERATIONS

GOHEALTH.MD,  Inc.  is a  development  stage  company  and  will be  engaged  in
providing through the Internet an advertising  network and Internet presence for
independently owned health food stores, health care providers and others through
an additional website owned by the Company, HEALTHMALL.COM.

GOHEALTH.MD,  Inc. has  marketing  rights to more than 40 domain names (such as:
HERB.MD, NUTRITION.MD,  ARTHRITIS.MD,  VITAMIN.MD,  FAMILY.MD, and SPORTS.MD) in
the TLD (top level domain) .MD. A Florida company,  Domain Name Trust,  acquired
the .MD protocol from Moldova,  a small  European  country  formerly part of the
Soviet  Union.  Domain  Name Trust has been  licensed to sell  registrations  by
Moldova in Europe,  Canada and other English speaking countries.  The country of
Moldova benefits economically from this arrangement, receiving $35 for each name
sold.

The  Company  believes  that .MD is the  first of a new  generation  of  website
addresses  and it is a  natural  and  intuitive  address  that  makes  sense for
physicians  and those in the broad  medical  community,  as well as those  whose
personal initials,  corporate initials,  state of residence (i.e. Maryland),  or
title (i.e. Managing Director) are the letters .MD.

 .MD is a top level domain  (TLD),  comparable in purpose to the top level domain
 .COM,  .NET, or .ORG. The Company believes that in the future a top level domain
name will no longer be as primitive as the first TLDs. Secondly, the names still
available within these domains are finite. Once a name is registered,  it is not
available to anyone else.  Eventually,  all of the domains may be taken. .MD was
first made available in 1998.

The Company believes it has several  advantages over other companies that may be
offering a similar product. The Company expects to develop a significant revenue
stream over the next three years  through the  development  and marketing of its
Internet domain names. The  availability of capturing a large physician  network
(medical  doctors,  chiropractors,  dentists,  podiatrists,  osteopaths) to view
online  advertising  in exchange for the  establishment  of websites and hosting
services is one of the Company's  primary goals. The availability of having tens
of thousands of  physicians  guaranteed  viewing the  websites  establishes  the
significant  potential for advertising  revenue.  The Company also believes that
the same  potential  exists for the natural health food products  market.  It is
believed  that  individual  health food stores could be provided  with a webpage
either free of charge or for a nominal fee with free hosting and website  design
in exchange for guaranteed  viewing of certain web pages on a monthly basis.  In
exchange,  the Company  could  receive  advertising  revenue for the  guaranteed
visits to that particular site.

The  Company  also owns the  domains  ACCIDENT.MD,  ASK.MD  and  CALL911.MD  and
believes  that  management  will be able to  obtain  the  necessary  funding  to
commence its planned principal operations during the year 2000.


                                       41


<PAGE>



                                GOHEALTH.MD, INC.
                          (A DEVELOPMENT STAGE COMPANY)

                          NOTES TO FINANCIAL STATEMENTS

                               SEPTEMBER 30, 1999

                                   (Continued)

2.  PLAN OF OPERATIONS (Continued)

The Company is only recently organized and does not have any material assets and
has no previous  commercial  operations,  and therefore,  there is no history of
earnings or  operations  upon which to judge its future  success.  To date,  the
Company  has  been  engaged  in the  development  of its  business  plan and the
preparation  and  offering  of  a  Private  Placement  Memorandum.  The  Company
currently has not conducted any significant  business nor has the Company signed
any definitive agreements with any health food stores, health care providers, or
others.  Because of its lack of prior operations,  assets and industry position,
the Company must be considered a  development  stage  enterprise.  Consequently,
there can be no assurance that viable  commercial  operations can be achieved or
sustained by the Company even if it is  successful in raising all of the capital
it requires. As a development stage enterprise, the Company is subject to all of
the risks inherent in the establishment of a new business, including the absence
of a  significant  operating  history,  lack of market  recognition  and limited
banking  and  financial  relationships.  There  can  be no  assurance  that  the
Company's  proposed  operations  will  attract  a  sufficient  customer  base to
establish viable commercial  operations or that it will generate sufficient cash
flow to fund the future operations of the Company. The Company's growth strategy
is  largely  dependent  on the  marketing  of its  home  pages  through  various
marketing media, including but not limited to the Internet.

The market for the Company's  products will be characterized by rapidly changing
technology  and  continuing  development  of customer  requirements.  The future
success of the Company's  business will depend in large part upon its ability to
develop  and market its  products  at an  acceptable  cost,  develop  and market
products which meet changing  customer  needs,  and  successfully  anticipate or
respond to  technological  changes in customer  requirements on a cost-effective
and  timely  basis.  There  can  be no  assurance  that  the  Company's  product
development   efforts  will  be   successful   or  that  the  emergence  of  new
technologies,  industry  standards or customer  requirements will not render the
Company's technology or products obsolete or noncompetitive. In addition, to the
extent  that the Company  determines  that new  technologies  or  equipment  are
required to remain  competitive,  the  acquisition  and  implementation  of such
technologies and equipment are likely to require significant capital investments
by the  Company.  There can be no  assurance  that  sufficient  capital  will be
available in the future.  Operating results can also be significantly  adversely
affected  by  the  development  and  introduction  of  new  products  or by  the
establishment of better financed competition.

The Company intends to comply fully with industry rules and  regulations.  These
regulations vary  dramatically,  from region to region.  The Company can make no
assurances  that it will be able  to  meet or  comply  with  all the  regulatory
standards  affecting  Internet  service  in  every  jurisdiction  in the  world.
Furthermore,   management   cannot  predict  what  changes  may  occur  in  such
regulations in the future or give any assurances as to the Company's  ability to
continue its planned  operations in light of any such presently  unknown changes
in regulations applicable to the Company. The Company may be faced with the need
to incur  substantial  legal and professional  expenses in an effort to meet the
requirements of changing regulatory requirements.

The Company plans an aggressive  growth strategy for its clientele and products.
There  can be no  assurance  that  the  Company  will  be  successful  in  these
endeavors.  Forces that can  contribute  to the lack of success in  implementing
this  growth  strategy  include,   among  others:   (i)  regulatory  bodies  and
governmental  regulations  affecting  the  Company  and  its  operations,   (ii)
availability of funding on a timely basis and (iii) functionality. The Company's
growth  strategy  relies on its  ability to raise  further  capital and upon the
skills of its management.

                                       42


<PAGE>



                                GOHEALTH.MD, INC.
                          (A DEVELOPMENT STAGE COMPANY)

                          NOTES TO FINANCIAL STATEMENTS

                               SEPTEMBER 30, 1999

                                   (Continued)

3.  NOTES PAYABLE

The following is a summary of the Company's notes payable at September 30, 1999:

   Payable to William Hanna on demand, with interest accrued
     at 5% per annum, unsecured                                          $25,000

   Payable to William Hanna Consultants on March 29, 2000,
     with interest accrued at 5% per annum, unsecured                     10,000

   Payable to William Hanna Consultants on May 2, 2000, with
     interest accrued at 5% per annum, unsecured                           3,000
                                                                       ---------
                                                                         $38,000
                                                                       =========

4.  DUE TO OFFICER

As of September 30, 1999 the Company is indebted to its officer in the amount of
$21,622. This is a noninterest bearing loan payable on demand.

5.  PROVISION FOR INCOME TAXES

For the period of  inception  (February  23,  1999) to  September  30,  1999 the
Company had a loss of $109,126.  No tax expense or benefit has been  reported in
the financial statements due to the uncertainty of future operations.

6.  COMMON STOCK

The  authorized  capital stock of the Company  consists of 10,000,000  shares of
Common Stock, par value $.001 per share.

The Company issued 3,000,000 shares of Common Stock to the  incorporators of the
Company for $3,000.

The  Company  has  offered a total of 500  Units at a price of $5,200  per Unit,
which were  offered on a Abest  efforts,  all or none@ basis with respect to the
first 20 shares of the Company's Common Stock and a detachable warrant entitling
the holder to purchase  2,000 shares of Common Stock.  The Company is conducting
the  Offering  in such a manner  that the  Shares  will be sold only to  certain
Accredited  Investors as such term is defined in Rule 501 of  Regulation D under
the Act, and to not more than 35 other nonaccredited  investors, and who satisfy
any  additional  requirements  of their state of residency.  The pricing and the
terms of the securities have been arbitrarily determined by the Company and bear
no relationship to the Company's assets,  book value or results of operations or
any other generally  accepted criteria of value. The Units are being offered and
sold  exclusively  through the Company by its Officers,  as well as the selected
dealers,  if any, and their  officers,  directors and employees may purchase the
Units on the same terms and conditions as other investors.

                                       43


<PAGE>



                                GOHEALTH.MD, INC.
                          (A DEVELOPMENT STAGE COMPANY)

                          NOTES TO FINANCIAL STATEMENTS

                               SEPTEMBER 30, 1999

                                   (Continued)

6.  COMMON STOCK (Continued)

The minimum  subscription  price to  investors  is for $10,400 for 2 units.  The
Company  may,  in its sole  discretion,  accept  subscription  offers for lesser
amounts if deemed to be in the Company's  best interest and insofar as permitted
by law.

Each Unit Warrant entitles the registered holder thereof to purchase up to 2,000
shares of Common Stock at a price of $2.50 per share  (subject to  adjustment as
described  herein) at any time prior to the  earlier of (i) May 31, 2003 or (ii)
the date that the respective Unit Warrant is redeemed. If the Company is able to
complete an initial public offering (AIPO@) of the Common Stock,  then beginning
12 months after the IPO, the Unit  Warrants will be subject to redemption by the
Company at $0.10 per share of the Common Stock that  remains,  subject each Unit
Warrant on thirty (30) days prior  written  notice if the average  closing sales
price of the Common Stock over any 10 consecutive trading days equals or exceeds
150% of the IPO price per share of Common Stock.

As of  September  30, 1999 and in  connection  with the private  placement,  the
Company issued 76,000 shares of its Common Stock and 76,000 detachable  Warrants
and received proceeds of $197,600.

Also,  as of  September  30,  1999,  the Company  issued  4,000 Shares and 4,000
Warrants in  connection  with a website  purchase and valued  these  services at
$10,400.

Subsequent to September 30, 1999 and in connection  with the private  placement,
the Company issued additional 22,000 Common Stock shares and 22,000 Warrants and
received proceeds of $52,000 and consulting services valued at $5,200.

7.  COMMITMENTS AND CONTINGENCIES

EMPLOYEE STOCK OPTIONS

The  Company  has  reserved  a total of 500,000  shares of its Common  Stock for
grants of incentive stock options to employees.  A total of 230,000 options with
an exercise price of $.50 per share with terms expiring seven (7) years from the
respective dates of the grant have been granted to two employees as of September
30, 1999.

All future grants will have an exercise price above $1.50 per share.

OTHER STOCK OPTIONS

On May 6, 1999 the Company  granted  30,000  options to a consulting  firm at an
exercise price of $.50 per share. These options will have no expiration date and
contain two piggyback registration rights.

On May 26,  1999 the  Company  granted  10,000  options  to  investment  banking
consultants at exercise prices of $.50 per share for 5,000 options and $1.00 for
5,000 options. These options contain piggyback registration rights.

On  August  27,  1999 the  Company  granted  20,000  options  to a  professional
consultant.  The options,  which  include  piggyback  registration  rights,  are
exercisable 10,000 at an exercise price of $1.00 and 10,000 at an exercise price
of $1.50.

                                       44


<PAGE>



                                GOHEALTH.MD, INC.
                          (A DEVELOPMENT STAGE COMPANY)

                          NOTES TO FINANCIAL STATEMENTS

                               SEPTEMBER 30, 1999

                                   (Continued)

7.  COMMITMENTS AND CONTINGENCIES (Continued)

OTHER STOCK OPTIONS (Continued)

In August 1999 the Company granted to two consultants nonqualified stock options
for the right to purchase  175,000  shares of the Company's  Common  Stock.  The
options  have an  exercise  price of $1.00 and  expire on August  27,  2006 and
piggyback registrations rights.

The fair value of the other stock options were  estimated  according to FASB 123
at the grant  dates  using  the  Black  Scholes  option  pricing  model and were
determined to be immaterial.

GOVERNMENT REGULATION

The Company is subject to local state and federal laws of the jurisdiction  that
it  operates  in.  The  Company  also  believes  that it will be  subject to all
jurisdictions of its participants and clients.

LITIGATION

The  Company  is  not a  party  to any  litigation,  nor  to  the  knowledge  of
management, is any viable litigation currently threatened against the Company or
any of its officers or directors in their capacity as such.

EMPLOYMENT AGREEMENTS

The current  officers and directors of the Company have entered into  agreements
with the Company that state that they will forego  salaries  until the Company's
revenues exceed $1,000,000 or at the discretion of the Board of Directors.

YEAR 2000 ISSUES

The year 2000 issue  arises  because  many  computerized  systems use two digits
rather than four to identify a year.  Date-sensitive  systems may  recognize the
year 2000 as 1900 or some other date, resulting in errors when information using
2000 dates is processed. In addition, similar problems may arise in some systems
which use certain dates in 1999 to represent  something  other than a date.  The
effects of the Year 2000 Issue may be experienced  before,  on, or after January
1, 2000, and, if not addressed, the impact on operations and financial reporting
may range from minor errors to significant  systems  failures which could affect
an entity's  ability to conduct normal business  operations.  It is not possible
that all aspects of the Year 2000 Issue  affecting the Company,  including those
related to the efforts of customers or third  parties,  will be fully  resolved.
The Company has verified that its  significant  service  providers are currently
Year 2000 compliant

8.  MERGER AGREEMENT

On September 30, 1999 the Company  entered into a Stock  Exchange  Agreement and
Plan of Merger with Nugget Exploration,  Inc. (ANugget@), a publicly held Nevada
corporation  without  current  operations  and seeking a merger with a corporate
entity with planned operations.  The agreement provides that at the closing date
each issued and outstanding common shares of the Company shall be converted into
and exchanged for one fully paid and nonassessable Nugget share.

                                       45


<PAGE>



                                GOHEALTH.MD, INC.

                          (A DEVELOPMENT STAGE COMPANY)

                          NOTES TO FINANCIAL STATEMENTS

                               SEPTEMBER 30, 1999

                                   (Continued)

8.  MERGER AGREEMENT (Continued)

In  addition,  the  agreement  provided  that  Nugget  would  assume  all of the
Company's  rights  and  obligations  under all  outstanding  stock  options  and
warrants. Upon the closing of the transaction,  which was subject to a number of
conditions,  including  shareholder approvals and regulatory  requirements,  the
stockholders of The Company will own  approximately  81% of Nugget and therefore
have control.

On November 10, 1999 the merger  became  effective and the  stockholders  of The
Company were issued  3,102,000  shares of Nugget common  stock,  par value $.01,
which resulted in 3,799,117 shares of Nugget common stock  outstanding after the
merger.

The  transaction is expected to be accounted for as a purchase,  however,  since
the stockholders of The Company will own approximately 81% of Nugget outstanding
shares and therefore have control, the Company will be deemed to be the acquirer
and surviving entity.

9.  SUBSEQUENT EVENTS

On November 16, 1999 the Company entered into a Management  Consulting Agreement
(AAgreement@) for management  consulting,  strategic  planning and marketing and
advisor  services.   The  Agreement  requires  the  Company  to  compensate  the
management  consulting  company $5,000 per month through October 2000,  issue to
the  consultant  300,000  shares of its common stock and requires the Company to
issue  warrants to the  consultant to purchase  500,000  shares of the Company's
common  stock at  exercise  prices of $1.00 for the first  100,000 and $2.00 per
share for the next 400,000.

In  connection  with this  transaction,  the  Company  will record an expense of
$1,050,000 for the 300,000 shares grant and $850,000 for the intrinsic  value of
the warrants to purchase 500,000 shares of the Company's common stock.

On December 13, 1999 50,000 of the $1.00 warrants were exercised.

On December 22, 1999 the Company issued,  in connection with a private placement
offering, warrants to purchase 302,000 shares of its common stock at an exercise
price of $1.00 per share till  December  31, 2002.  The  warrants  were sold for
$1.00 per common stock purchase  warrants and resulted in the Company  receiving
proceeds of $302,000. The market price of the Company's common stock at December
22, 1999 was $5.00 and created a  beneficial  conversion  feature to the warrant
holders.  The Company  intends to record  $906,000 as a charge in computing  net
income or loss on common stock.

                                       46


<PAGE>



<TABLE>
<CAPTION>
                                              GOHEALTH.MD, INC.
                                     PRO FORMA CONSOLIDATED BALANCE SHEET

                                              SEPTEMBER 30, 1999
                                                 (Unaudited)

                                                                 Nugget
                                                GoHealth       Exploration
                                                  .MD,           , Inc.
                                                               August 31,
                                                  Inc.            1999            Pro Forma
                                                Sept. 30,                        Adjustment         Pro Forma
                                                   1999        (Unaudited)             s             Results
                                        -------------------------------------------------------------------------
<S>                                          <C>              <C>               <C>               <C>
ASSETS

Current Assets:
   Cash and cash equivalents                    $    109,016   $    3,253       $      1,400(2)     $ 1,669,669
                                                                                      52,000(1)
                                                                                     900,000(4)
                                                                                     604,000(5)
  Accounts receivable                                   48                                                 48
  Stock subscription receivable                      1,400                            (1,400)(2)             0
  Domain names available for                                                                                0
    sale                                            27,577                                             27,577
                                               ===========      ===========     ================     ============
        Total Current Assets                       138,041          3,253          1,556,000         1,697,294


Other Assets - Website Costs                        65,955                                             65,955
                                               ===========      ===========     ===============     ============

                                               $   203,996     $    3,253        $ 1,556,000         1,763,249
                                               ===========      ===========     ===============     ============

LIABILITIES AND STOCKHOLDERS'
  EQUITY

Current Liabilities:

  Notes payable                                $    38,000     $    7,380        $                 $    45,380
  Accounts payable                                  42,500         22,622                               65,122
  Accrued interest                                                  8,906                                8,906
  Due to officers                                   21,622                                              21,622
                                               ===========      ===========     ===============     ============
         Total Current Liabilities                 102,122         38,908                              141,030
                                               ===========      ===========     ===============     ============

Commitments and Contingencies                            0              0                  0                 0

Stockholders' Equity:
  Common stock                                       3,080          6,971                 20(1)         49,001
                                                                                           2(3)
                                                                                       3,000(4)
                                                                                       5,000(4)
                                                                                       3,020(5)
                                                                                      27,908(7)

Additional paid-in-capital                         207,920      3,536,930             51,980(1)      4,493,544
                                                                                       5,198(3)
                                                                                   1,047,000(4)
                                                                                   1,745,000(4)
                                                                                     600,980(5)
                                                                                     906,000(6)
                                                                                  (3,607,464)(7)

Unamortized Consulting Expense                                                    (1,050,000)(4)    (1,900,000)
                                                                                    (850,000)(4)

Retained deficit                                                                      (5,200)(3)
                                                                                    (906,000)(6)
                                                   (109,126)   (3,579,556)           3,579,556(7)   (1,020,326)
                                               =============    ===========     ================    ============
                                                    101,874                           1,556,000      1,622,219
          Total Stockholders' Equity                              (35,655)
                                               ===========      ===========     ================    ============
                                                                                                             0
                                                    203,99                           1,556,00         1,763,24
                                               $         6    $       3,253     $           0     $          9
                                               ===========    =============     ================    ============
</TABLE>
- --------------------

See notes to Pro Forma Consolidated
Financial Data.

                                                           47


<PAGE>



<TABLE>
<CAPTION>
                                                                         GOHEALTH.MD, INC.

                                                      PRO FORMA COMBINED CONSOLIDATED STATEMENT OF OPERATIONS
                                                                            (Unaudited)

                                             For the Year Ended                For the Three Months Ended August 31, 1999 (Nugget)
                                               May 31, 1999                  For the Four Months Ended September 30, 1999 (GoHealth)
                            ========================================================================================================
                                                 Nugget                                     Nugget
                                GoHealth.MD,   Exploration,    Pro Forma    GoHealth.MD,  Exploration,    Pro Forma      Pro Forma
                                    Inc.          Inc.          Results         Inc.          Inc.       Adjustments      Results
                                -----------   -----------   --------------  -----------   ----------   --------------  ------------
<S>                            <C>           <C>            <C>            <C>            <C>           <C>           <C>
Revenues:
  Ad revenue                   $             $               $              $      48     $             $              $         48
  Domain name sales                    400                           400          900                                           900
  Cost of sales                      (280)                          (280)        (630)                                         (630)
                               -----------    ----------      -----------   -----------   ----------    -----------     ------------
Gross Profit (Loss)                    120                           120          318                                           318
                                -----------   ----------      -----------   -----------   ----------    -----------     ------------
Costs and Expenses:
  General and administrative
    expenses                        20,764      250,304          271,068       88,800         5,288        5,200(3)          99,288
                               -----------   -----------      -----------   -----------   ----------    -----------     ------------
Loss from Operations               (20,644)    (250,304)        (270,948)     (88,482)       (5,288)      (5,200)           (98,970)

Other Income:
  Gain on sale of asset                         588,499          588,499
                               ===========  ============     ============   ===========   ===========   ===========      ===========
Net Income (Loss) before
  Extraordinary Item              (20,644)      338,195          317,551      (88,482)       (5,288)      (5,200)           (98,970)

Gain on Extinguishment
   of Debt                                    1,384,411        1,384,411
Beneficial Conversion Feature
  Series A Warrants/Dividends                                                                           (906,000)(6)       (906,000)
                               -----------  -----------      -----------  -----------     ----------   -----------       -----------

Net Income (Loss) on
  Common Stock                 $  (20,644)  $ 1,722,606   $    1,701,962  $ (88,482)      $  (5,288)  $ (911,200)      $ (1,004,970)
                               ===========  ============    ============ ===========      ===========  ===========       ===========

Net Income (Loss) per Share:
  Basic                                                                   $   (0.03)      $   (0.01)                          (0.21)
                                                                         ===========     ===========                     ===========
  Diluted                                                                $    (0.03)     $    (0.01)                   $      (0.21)
                                                                         ===========     ===========                     ===========
  Basic common shares
    outstanding                                                           3,080,000         697,117                       4,901,117

  Diluted common shares
    outstanding                                                           3,080,000         697,117                       4,901,117
</TABLE>

- --------------------

See notes to Pro Forma
Consolidated Financial Data.

                                                                  48


<PAGE>




             SUMMARY UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL DATA

The following  unaudited pro forma consolidated  financial data for GoHealth.MD,
Inc.  ("GoHealth") is based on the historical  financial  statements of GoHealth
and Nugget  Exploration,  Inc.  (collectively with its subsidiaries  referred to
herein as "Nugget") which appear  elsewhere in this  Registration  Statement and
has been  prepared on a pro forma  basis to give effect to the merger  under the
purchase method of accounting,  as if the transaction had occurred at January 1,
1998 for each operating period  presented.  The unaudited pro forma  information
was  prepared  based upon  certain  assumptions  described  below and may not be
indicative of results that actually would have occurred had the merger  occurred
at the beginning of the last full fiscal year  presented or of results which may
occur in the future.  The unaudited pro forma  consolidated  financial  data and
accompanying  notes  should be read in  conjunction  with the annual and interim
financial  statements  and  notes  thereto  of  Nugget  and  GoHealth  appearing
elsewhere herein and incorporated by reference into this Registration Statement.

The  unaudited  pro forma  consolidated  balance  sheet as of September 30, 1999
presents the financial  position of Nugget as if the merger had occurred on that
date  and was  prepared  utilizing  the  audited  GoHealth  balance  sheet as of
September 30, 1999 and the unaudited Nugget balance sheet as of August 31, 1999.
The unaudited pro forma consolidated statement of operations presented,  assumes
the merger occurred at the beginning of the periods presented.  It should not be
assumed that Nugget and GoHealth  would have  achieved the  unaudited  pro forma
consolidated  results if they had  actually  been  combined  during the  periods
shown.

The merger is expected to be accounted for as a purchase.  The  stockholders  of
GoHealth  will  receive  one share of common  stock of Nugget  for each share of
GoHealth  common stock held,  resulting in the current  stockholders of GoHealth
owning approximately 81% of Nugget common stock.

The  unaudited  pro  forma  consolidated  results  are  based on  estimates  and
assumptions, which are preliminary and have been made solely for the purposes of
developing  such pro forma  information.  The unaudited  pro forma  consolidated
results are not  necessarily  an  indication of the results that would have been
achieved had such  transactions  been  consummated as of the dates  indicated or
that may be achieved in the future.

The unaudited pro forma combined  results should be read in conjunction with the
historical consolidated financial statements and notes thereto set forth herein,
and other  financial  information  pertaining  to GoHealth and Nugget  including
Management's  Discussion  and  Analysis of  Financial  Condition  and Results of
Operations  of  GoHealth,  Management's  Discussion  and  Analysis of  Financial
Condition and Results of Operations of Nugget and Risk Factors".

                                       49



<PAGE>


                                GOHEALTH.MD, INC.

                 NOTES TO PRO FORMA CONSOLIDATED FINANCIAL DATA

                               SEPTEMBER 30, 1999

On November 10, 1999 GoHealth.MD, Inc. (AGoHealth@) and Nugget Exploration, Inc.
(collectively  with it's subsidiaries  herein referred to as ANugget@  completed
their planned Stock  Exchange  Agreement and Plan of Merger.  Under the terms of
the  Agreement,  GoHealth will become a wholly owned  subsidiary of Nugget and a
wholly owned  subsidiary of GoHealth will merge with and into Nugget.  Following
the  merger,  GoHealth  will  be  a  wholly  owned  subsidiary  of  Nugget.  The
stockholders  of GoHealth  will  receive one share of common stock of Nugget for
each share of GoHealth common stock held,  resulting in the current stockholders
of GoHealth owning approximately 81% of Nugget common stock.

The merger is expected to be  accounted  for as a purchase.  However,  since the
stockholders  of  GoHealth  will own  approximately  81% of  Nugget  outstanding
shares,  and therefore have control,  they will be deemed to be the acquirer and
no step up in basis will be  reflected  and no goodwill  will be recorded by the
company.

PRO FORMA ADJUSTMENTS

      1) To record private  placement  offering  proceeds of  GoHealth.MD,  Inc.
         subsequent to September 30, 1999 and the  issuance of  20,000 shares of
         common stock, 20,000 warrants to purchase common stock  and the receipt
         of corresponding cash proceeds totaling $52,000.

      2) To record  the receipt of  stock subscriptions receivable subsequent to
         September 30, 1999.

      3) To record  the  issuance  of  2,000 shares  of  common stock and  2,000
         warrants  to  purchase  common  stock  subsequent to September 30, 1999
         to a consultant for services valued at $5,200.

      4) On November 16, 1999 the Company  entered into a  Management Consulting
         Agreement for management consulting, strategic  planning and  marketing
         and advisor services. The Agreement requires the Company to  compensate
         the management consulting company $5,000 per month through October 2000
         issue to the consultant 300,000 shares of its common stock and requires
         the  Company  to issue  warrants  to  purchase  500,000  shares  of the
         Company's  common  stock at  exercise  prices  of $1.00  for the  first
         100,000 and $2.00 per share for the next 400,000.  In  connection  with
         this transaction,  the Company will record an expense of $1,050,000 for
         the 300,000 shares granted and $850,000 for the intrinsic  value of the
         warrants to purchase 500,000 shares of the Company's common stock

      5) On December 22, 1999 the Company  issued, in  connection with a private
         placement offering,  warrants to purchase  302,000 shares of its common
         stock at an exercise price of $1.00 per share until  December 31, 2002.
         The warrants  were  sold for $1.00 per common stock  purchase  warrants
         and  resulted in  the  Company  receiving  proceeds  of  $302,000.  The
         market  price  of the  Company's  common  stock at  December  22,  1999
         was $5.00 and  created a beneficial  conversion feature to the  warrant
         holders.

      6) In connection with the  transaction  described in  Note 5, the  Compan
         will record  $906,000 as a charge in  computing  net  income or loss on
         common stock.

      7) To record issuance of 3,102,000 shares of common stock of Nugget to the
         stockholders of GoHealth and the  elimination of  Nugget's  accumulated
         deficit as a result of the merger.

                                       50




                                                                   Exhibit 23.1

                    [Letterhead of Jones, Jensen & Company]


Consent of Jones, Jensen & Co.

                        CONSENT OF INDEPENDENT AUDITORS'


Board of Directors
GoHealth.MD, Inc.

(fka Nugget Exploration, Inc.)
Cherry Hill, New Jersey

We hereby  consent to the use of our audit  report  dated  July 21,  1999 in the
Schedule 14C of GoHealth.MD,  Inc. (fka Nugget  Exploration,  Inc.) for the year
ended May 31, 1999 and all references to our firm included in the Schedule 14C.


/s/
Jones, Jensen & Company
Salt Lake City, Utah
December 29, 1999



                                       18







                                                                   Exhibit 23.1
                       [Letterhead of Samuel Klein & Co.]


Consent of Samuel Klein & Co.

                         CONSENT OF INDEPENDENT AUDITORS

We consent to the  reference to our firm under the caption  AExperts@ and to the
use of our  report  dated  December  27,  1999 on the  financial  statements  of
GoHealth .MD, Inc., that is made a part of this Registration Statement.


                                            /S/
                                           SAMUEL KLEIN AND COMPANY

Newark, New Jersey
December 29, 1999

                                       19




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission